Vivakor, Inc.
We have audited the accompanying consolidated balance sheet of Vivakor,
Inc. (the Company) as of December 31, 2021 and 2020, and the related consolidated statements of operations, stockholders’ equity
(deficit), and cash flows for the years then ended, and the related notes (collectively referred to as the “consolidated financial
statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position
of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for the years then ended in conformity
with accounting principles generally accepted in the United States of America.
As discussed in Note 23 to the consolidated financial statements, the
Company filed an incorrect version of the consolidated financial statements and Form 10-K, due to administrative errors, on April 15,
2022. The December 31, 2021, consolidated financial statements have been restated to reflect the correct version of the consolidated financial
statements that we audited. In our opinion, such corrections are appropriate and have now been properly reported.
These financial statements are the responsibility of the entity’s
management. Our responsibility is to express an opinion on the entity’s consolidated financial statements based on our audits. We
are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are
required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB.
Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free
of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit
of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control
over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control
over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material
misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those
risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating
the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.
We have served as the Company's auditor since
2021.
VIVAKOR, INC.
CONSOLIDATED BALANCE SHEETS
(As Restated)
| |
| | | |
| | |
| |
December 31, | |
| |
2021 | | |
2020 | |
ASSETS | |
| | |
| |
Current assets: | |
| | | |
| | |
Cash and cash equivalents | |
$ | 1,293,767 | | |
$ | 309,404 | |
Cash and cash equivalents attributed to variable interest entity | |
| 199,952 | | |
| 89,500 | |
Accounts Receivable, less allowances of $33,000 and $33,000, respectively | |
| 845 | | |
| 7,735 | |
Marketable securities | |
| 2,231,218 | | |
| 4,016,951 | |
Inventories | |
| 192,000 | | |
| 525,744 | |
Precious metal concentrate | |
| 1,166,709 | | |
| 1,166,709 | |
Other assets | |
| 73,245 | | |
| 87,052 | |
Total current assets | |
| 5,157,736 | | |
| 6,203,095 | |
| |
| | | |
| | |
Other investments | |
| 4,000 | | |
| 4,000 | |
Notes receivable | |
| 1,194,235 | | |
| 78,455 | |
Property and equipment, net | |
| 24,692,111 | | |
| 18,152,699 | |
Rights of use assets- operating leases | |
| 663,291 | | |
| 881,804 | |
License agreement, net | |
| 2,370,835 | | |
| 2,013,810 | |
Intellectual property, net | |
| 13,662,037 | | |
| 14,966,627 | |
Total assets | |
$ | 47,744,245 | | |
$ | 42,300,490 | |
| |
| | | |
| | |
LIABILITIES AND STOCKHOLDERS’ EQUITY AND TEMPORARY EQUITY | |
| | | |
| | |
Current liabilities: | |
| | | |
| | |
Accounts payable and accrued expenses | |
$ | 2,023,985 | | |
$ | 1,350,808 | |
Operating lease liabilities, current | |
| 287,769 | | |
| 276,699 | |
Loans and notes payable, current | |
| 1,511,447 | | |
| 1,196,037 | |
Loans and notes payable, current attributed to variable interest entity | |
| 3,416,379 | | |
| 735,000 | |
Long-term debt, current | |
| 3,256 | | |
| 1,020 | |
Total current liabilities | |
| 7,242,836 | | |
| 3,559,564 | |
| |
| | | |
| | |
Operating lease liabilities, long term | |
| 434,109 | | |
| 618,696 | |
Loans and notes payable, long term | |
| 1,185,970 | | |
| 914,661 | |
Long-term debt | |
| 6,171,298 | | |
| 4,950,640 | |
Deferred income tax liabilities | |
| 5,156,899 | | |
| 6,207,905 | |
Total liabilities | |
| 20,191,112 | | |
| 16,251,466 | |
| |
| | | |
| | |
Redeemable, convertible preferred stock, $.001 par value; 11,600,000 shares authorized;(1) | |
| | | |
| | |
Series B- 12.5%, cumulative,
none
and 216,916
issued and outstanding as of December 31, 2021 and 2020(1) | |
| – | | |
| 1,301,500 | |
Series B-1- none and 467,728 issued and outstanding as of December 31, 2021 and 2020(1) | |
| – | | |
| 3,507,981 | |
Series
C-1- none
and 255,290
issued and outstanding as of December 31, 2021 and 2020(1) | |
| – | | |
| 4,550,977 | |
Total temporary equity | |
| – | | |
| 9,360,458 | |
| |
| | | |
| | |
Stockholders' equity: | |
| | | |
| | |
Convertible, preferred stock, $.001 par value;
3,400,000 shares authorized;(1) |
|
|
|
|
|
|
|
|
Series A- 66,667 issued and outstanding
(1) |
|
|
67 |
|
|
|
67 |
|
Common stock, $.001 par value; 41,666,667 shares authorized; 12,330,859 and 11,255,967 were issued and outstanding as of December 31, 2021 and 2020(1) | |
| 12,331 | | |
| 11,256 | |
Additional paid-in capital | |
| 58,279,590 | | |
| 45,623,146 | |
Treasury stock, at cost | |
| (20,000 | ) | |
| (20,000 | ) |
Accumulated deficit | |
| (35,731,359 | ) | |
| (30,204,992 | ) |
Total Vivakor, Inc. stockholders' equity | |
| 22,540,629 | | |
| 15,409,477 | |
Noncontrolling interest | |
| 5,012,504 | | |
| 1,279,089 | |
Total stockholders' equity | |
| 27,553,133 | | |
| 16,688,566 | |
Total liabilities and stockholders’ equity and temporary equity | |
$ | 47,744,245 | | |
$ | 42,300,490 | |
(1) |
Share and per share amounts have been retroactively adjusted to reflect the one-for-thirty reverse stock split effective February 14,
2022. See Note 1 – Organization and Basis of Presentation for additional information |
See accompanying notes to consolidated financial
statements
VIVAKOR, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(As Restated)
| |
| | | |
| | |
| |
Year Ended | |
| |
December 31, | |
| |
2021 | | |
2020 | |
| |
| | |
| |
Revenues | |
$ | 1,088,428 | | |
$ | 1,457,781 | |
Cost of revenues | |
| 1,050,676 | | |
| 1,356,378 | |
Gross profit | |
| 37,752 | | |
| 101,403 | |
Operating expenses: | |
| | | |
| | |
Sales and marketing | |
| 849,107 | | |
| 567,290 | |
General and administrative | |
| 4,652,069 | | |
| 2,806,238 | |
Bad debt expense | |
| – | | |
| 13,645 | |
Amortization and depreciation | |
| 1,462,492 | | |
| 1,562,622 | |
Total operating expenses | |
| 6,963,668 | | |
| 4,949,795 | |
Loss from operations | |
| (6,925,916 | ) | |
| (4,848,392 | ) |
Other income: | |
| | | |
| | |
Equity investment loss | |
| – | | |
| (37,665 | ) |
Gain (loss) on disposition of asset | |
| 87,044 | | |
| (121,428 | ) |
Unrealized gain (loss) on marketable securities | |
| (1,094,054 | ) | |
| 2,614,338 | |
Interest income | |
| 3,312 | | |
| 35,344 | |
Interest expense | |
| (501,598 | ) | |
| (86,162 | ) |
Other income | |
| 125,299 | | |
| 39,560 | |
Total other income (expense) | |
| (1,379,997 | ) | |
| 2,443,987 | |
Loss before provision for income taxes | |
| (8,305,913 | ) | |
| (2,404,405 | ) |
Benefit (provision) for income taxes | |
| 1,050,207 | | |
| (466,964 | ) |
Consolidated net loss | |
| (7,255,706 | ) | |
| (2,871,369 | ) |
Less: Net loss attributable to noncontrolling interests | |
| (1,771,535 | ) | |
| (687,672 | ) |
Net loss attributable to Vivakor, Inc. | |
$ | (5,484,171 | ) | |
$ | (2,183,697 | ) |
| |
| | | |
| | |
Net loss attributable to common shareholders | |
$ | (5,484,171 | ) | |
$ | (2,183,697 | ) |
Dividend on preferred stock | |
| 42,196 | | |
| 172,795 | |
Net income loss to parent | |
$ | (5,526,367 | ) | |
$ | (2,356,492 | ) |
| |
| | | |
| | |
Basic and diluted net loss per share (1) | |
$ | (0.46 | ) | |
$ | (0.23 | ) |
| |
| | | |
| | |
Basic weighted average common shares outstanding (1) | |
| 11,976,116 | | |
| 10,310,167 | |
(1) |
Share and per share amounts have been retroactively adjusted to reflect the one-for-thirty reverse stock split effective February 14,
2022. See Note 1 Organization and Basis of Presentation for additional information |
See accompanying notes to consolidated financial
statements
VIVAKOR, INC.
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’
EQUITY(DEFICIT)
(As Restated)
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
|
Series A Preferred Stock | |
Common Stock | |
Additional Paid-in | |
Treasury | |
Accumulated | |
Non-controlling | |
Total Stockholders' Equity | |
|
Shares | |
Amount | |
Shares | |
Amount | |
Capital | |
Stock | |
Deficit | |
Interest | |
(Deficit) | |
December
31, 2019(1) |
| 66,667 | |
$ | 67 | |
| 9,511,465 | |
$ | 9,511 | |
$ | 25,071,709 | |
$ | (20,000 | ) |
$ | (27,848,500 | ) |
| 1,341,854 | |
$ | (1,445,359 | ) |
Common
Stock issued for reduction in stock payable(1) |
| – | |
| – | |
| 666,667 | |
| 667 | |
| 11,799,333 | |
| – | |
| – | |
| – | |
| 11,800,000 | |
Common
Stock issued for a reduction in liabilities(1) |
| – | |
| – | |
| 9,164 | |
| 9 | |
| 135,984 | |
| – | |
| – | |
| – | |
| 135,993 | |
Common
Stock issued for cash(1) |
| – | |
| – | |
| 7,600 | |
| 8 | |
| 41,020 | |
| – | |
| – | |
| – | |
| 41,028 | |
Common
Stock issued for services(1) |
| – | |
| – | |
| 23,333 | |
| 23 | |
| 281,208 | |
| – | |
| – | |
| – | |
| 281,231 | |
Conversion
of temporary equity Series B, B-1, and C-1 Preferred Stock to Common Stock(1) |
| – | |
| – | |
| 1,037,738 | |
| 1,038 | |
| 7,592,778 | |
| – | |
| – | |
| – | |
| 7,593,816 | |
Stock options issued for services |
| – | |
| – | |
| – | |
| – | |
| 555,000 | |
| – | |
| – | |
| – | |
| 555,000 | |
Stock based compensation |
| – | |
| – | |
| – | |
| – | |
| 146,114 | |
| – | |
| – | |
| – | |
| 146,114 | |
Issuance of noncontrolling interest |
| – | |
| – | |
| – | |
| – | |
| – | |
| – | |
| – | |
| 624,907 | |
| 624,907 | |
Dividend paid in Series B-1 Preferred
Stock |
| – | |
| – | |
| – | |
| – | |
| – | |
| – | |
| (172,795 | ) |
| – | |
| (172,795 | ) |
Net loss |
| – | |
| – | |
| – | |
| – | |
| – | |
| – | |
| (2,183,697 | ) |
| (687,672 | ) |
| (2,871,369 | ) |
December 31,
2020(1) |
| 66,667 | |
$ | 67 | |
| 11,255,967 | |
$ | 11,256 | |
$ | 45,623,146 | |
$ | (20,000 | ) |
$ | (30,204,992 | ) |
| 1,279,089 | |
$ | 16,688,566 | |
Common
Stock issued for services(1) |
| – | |
| – | |
| 33,667 | |
| 34 | |
| 437,970 | |
| – | |
| – | |
| – | |
| 438,004 | |
Common
Stock issued for a reduction of liabilities(1) |
| – | |
| – | |
| 68,611 | |
| 68 | |
| 495,731 | |
| – | |
| – | |
| – | |
| 495,799 | |
Common
Stock issued for the purchase of a license(1) |
| | |
| | |
| 16,667 | |
| 17 | |
| 224,983 | |
| – | |
| – | |
| – | |
| 225,000 | |
Conversion
of temporary equity Series B, B-1, and C-1 Preferred Stock to Common Stock(1) |
| – | |
| – | |
| 955,947 | |
| 956 | |
| 9,466,648 | |
| – | |
| – | |
| – | |
| 9,467,604 | |
Stock options issued for services |
| – | |
| – | |
| – | |
| – | |
| 1,585,000 | |
| – | |
| – | |
| – | |
| 1,585,000 | |
Stock based compensation |
| – | |
| – | |
| – | |
| – | |
| 446,112 | |
| – | |
| – | |
| – | |
| 446,112 | |
Distributions paid by
noncontrolling interest |
| – | |
| – | |
| – | |
| – | |
| – | |
| – | |
| – | |
| (55,050 | ) |
| (55,050 | ) |
Issuance of noncontrolling interest
for a reduction of debt |
| – | |
| – | |
| – | |
| – | |
| – | |
| – | |
| – | |
| 5,560,000 | |
| 5,560,000 | |
Dividend paid in Series B-1 Preferred
Stock |
| – | |
| – | |
| – | |
| – | |
| – | |
| – | |
| (42,196 | ) |
| – | |
| (42,196 | ) |
Net (loss) |
| – | |
| – | |
| – | |
| – | |
| – | |
| – | |
| (5,484,171 | ) |
| (1,771,535 | ) |
| (7,255,706 | ) |
December 31, 2021 |
| 66,667 | |
$ | 67 | |
| 12,330,859 | |
$ | 12,331 | |
$ | 58,279,590 | |
$ | (20,000 | ) |
$ | (35,731,359 | ) |
$ | 5,012,504 | |
$ | 27,553,133 | |
(1) |
Share and per share amounts have been retroactively adjusted to reflect the one-for-thirty reverse stock split effective February 14,
2022. See Note 1 – Organization and Basis of Presentation for additional information |
See accompanying notes to consolidated financial
statements
VIVAKOR, INC.
CONSOLIDATED STATEMENT OF CASH FLOWS
(As Restated)
| |
| | | |
| | |
| |
Year Ended | |
| |
December 31, | |
| |
2021 | | |
2020 | |
OPERATING ACTIVITIES: | |
| | | |
| | |
Consolidated net loss | |
$ | (7,255,706 | ) | |
$ | (2,871,369 | ) |
Adjustments to reconcile net income to net cash used in operating activities: | |
| | | |
| | |
Depreciation and amortization | |
| 1,462,492 | | |
| 1,562,622 | |
Bad debt expense | |
| – | | |
| 13,645 | |
Forgiveness of notes payable | |
| (90,711 | ) | |
| – | |
Equity investment loss | |
| – | | |
| 37,665 | |
Loss (gain) on disposition of asset | |
| (87,044 | ) | |
| 121,428 | |
Common stock options issued for services | |
| 1,585,000 | | |
| 555,000 | |
Common stock issued for services | |
| 438,004 | | |
| 281,231 | |
Unrealized gain (loss) marketable securities | |
| 1,094,054 | | |
| (2,614,338 | ) |
Deferred income taxes | |
| (1,051,007 | ) | |
| 466,164 | |
Stock-based compensation | |
| 446,112 | | |
| 146,114 | |
Changes in operating assets and liabilities: | |
| | | |
| | |
Accounts receivable | |
| 6,890 | | |
| (19,735 | ) |
Inventory | |
| – | | |
| – | |
Other assets | |
| 13,807 | | |
| (2,549 | ) |
Precious metal concentrate | |
| – | | |
| 16,519 | |
Right of use assets | |
| 218,513 | | |
| 285,345 | |
Operating lease liabilities | |
| (218,513 | ) | |
| (285,345 | ) |
Accounts payable | |
| 38,128 | | |
| 517,931 | |
Accrued interest on notes receivable | |
| (3,313 | ) | |
| (35,344 | ) |
Accrued interest on notes payable | |
| 501,598 | | |
| 71,361 | |
Net cash used in operating activities | |
| (2,901,696 | ) | |
| (1,753,655 | ) |
| |
| | | |
| | |
INVESTING ACTIVITIES: | |
| | | |
| | |
Issuance of notes receivable | |
| – | | |
| (10,441 | ) |
Payment on costs of patents | |
| (13,366 | ) | |
| (18,854 | ) |
Purchase of a technology license | |
| (265,000 | ) | |
| – | |
Purchase of equipment | |
| (4,236,276 | ) | |
| (1,197,922 | ) |
Net cash used in investing activities | |
| (4,514,642 | ) | |
| (1,227,217 | ) |
| |
| | | |
| | |
FINANCING ACTIVITIES: | |
| | | |
| | |
Payment of long-term debt | |
| (7,735 | ) | |
| (116,535 | ) |
Proceeds from loans and notes payable | |
| 9,135,984 | | |
| 2,231,796 | |
Proceeds from sale of common stock | |
| – | | |
| 41,028 | |
Payment of notes payable | |
| (562,046 | ) | |
| (6,323 | ) |
Distributions to noncontrolling interest | |
| (55,050 | ) | |
| – | |
Issuance of noncontrolling interest | |
| – | | |
| 624,907 | |
Net cash provided by financing activities | |
| 8,511,153 | | |
| 2,774,873 | |
| |
| | | |
| | |
Net increase (decrease) in cash and cash equivalents | |
| 1,094,815 | | |
| (205,999 | ) |
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | |
| 398,904 | | |
| 604,903 | |
CASH AND CASH EQUIVALENTS, END OF PERIOD | |
$ | 1,493,719 | | |
$ | 398,904 | |
| |
| | | |
| | |
SUPPLEMENTAL CASHFLOW INFORMATION: | |
| | | |
| | |
Cash paid during the year for: | |
| | | |
| | |
Interest | |
| 390,843 | | |
| – | |
Income taxes | |
| – | | |
| – | |
| |
| | | |
| | |
Noncash transactions: | |
| | | |
| | |
Conversion of Series B, B-1, and C-1 Preferred Stock to Common Stock | |
$ | 9,467,604 | | |
$ | 7,593,816 | |
Common stock issued for a reduction in liabilities | |
$ | 495,799 | | |
$ | 11,935,993 | |
Conversion of note receivable to equity investment | |
$ | 81,768 | | |
$ | 809,578 | |
Noncontrolling interest issued for a reduction in liabilities | |
$ | 5,504,950 | | |
$ | – | |
Preferred stock Series C-1 issued for a reduction in liabilities | |
$ | 64,950 | | |
$ | – | |
Common stock issued for the purchase of a license | |
$ | 225,000 | | |
$ | – | |
Capitalized interest on construction in process | |
$ | 1,614,697 | | |
$ | 1,025,852 | |
Dividend paid in Series B-1 Preferred Stock | |
$ | 42,196 | | |
$ | 172,795 | |
Sale of marketable securities for note receivable | |
$ | 860,491 | | |
$ | – | |
Accounts payable on purchase of equipment | |
$ | 700,000 | | |
$ | – | |
See accompanying notes to consolidated financial
statements
VIVAKOR, INC.
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(As Restated)
Note 1. Organization and Basis of Presentation
Vivakor, Inc. (collectively “we”,
“us,” “our,” “Vivakor” or the “Company”) is a socially responsible operator, acquirer
and developer of clean energy technologies and environmental solutions, which is currently focused on soil remediation in the United States
and Kuwait, and we have corporate offices in Utah, California, and in Qatar. We specialize in the remediation of soil from properties
contaminated by or laden with heavy crude oil and other substances. The Company was originally organized on November 1, 2006 as a limited
liability company in the State of Nevada as Genecular Holdings, LLC. The Company’s name was changed to NGI Holdings, LLC on November
3, 2006. On April 30, 2008, the Company was converted to a C-corporation and changed its name to Vivakor, Inc. pursuant to Articles of
Conversion filed with the Nevada Secretary of State.
On December 18, 2020, our Board of Directors
and stockholders holding a majority of our outstanding voting shares, authorized a reverse stock split of each of the
outstanding shares of the Corporation’s common stock, $0.001
par value per share, as well as each of the outstanding shares of the Corporation’s preferred stock, at a ratio to be
determined by the Board of within a range of a minimum of a one-for-twelve (1-for-12)
to a maximum of one-for-forty (1-for-40)
(the “Reverse Stock Split Ratio”), with the exact ratio to be set at a number within this range as determined by the
Board in its sole discretion, with no change in par value. On February 14, 2022, we effected a 1-for-30
reverse split of our outstanding shares of common stock (the “Reverse Stock Split”) via the filing of a certificate of
change with the Nevada Secretary of State which was effective at the commencement of trading of our Common Stock. No fractional
shares of the Company’s common stock will be issued as a result of the Reverse Stock Split. Any fractional shares resulting
from the Reverse Stock Split will be rounded up to the nearest whole share. All issued and outstanding common stock, preferred
stock, and per share amounts in the consolidated financial statements and footnotes included herein have been retroactively adjusted
to reflect this reverse stock split for all periods presented.
COVID-19
On March 11, 2020, the World Health Organization
(“WHO”) declared the COVID-19 outbreak to be a global pandemic. In addition to the devastating effects on human life, the
pandemic is having a negative ripple effect on the global economy, leading to disruptions and volatility in the global financial markets.
Most U.S. states and many countries have issued policies intended to stop or slow the further spread of the disease.
COVID-19 and the U.S. response to the pandemic
are significantly affecting the economy. There are no comparable events that provide guidance as to the effect the COVID-19 pandemic may
have, and, as a result, the ultimate effect of the pandemic is highly uncertain and subject to change. We do not yet know the full extent
of the effects on the economy, the markets we serve, our business, or our operations. In March 2020 we temporarily suspended operations
in Kuwait and Utah due to COVID-19 government restrictions.
Note 2. Liquidity
We have historically suffered net losses and
cumulative negative cash flows from operations, and as of December 31, 2021, we had an accumulated deficit of approximately $35.7
million. As of December 31, 2021 we had cash of $1,493,719. To date we have financed our operations primarily through debt
financing, private equity offerings and our working interest agreements. For the year ended December 31, 2021 and 2020, we issued
none and $624,907 noncontrolling units of RPC Design and Manufacturing, LLC (“RDM”), respectively, made payments on our working interest agreement with RII of $7,735 and
$116,535, respectively, and we also received proceeds of $9,135,984 and $2,231,796 related to the issuance of convertible bridge
notes and other loans. For the years ended December 31, 2021 and 2020, as included in the proceeds above, we obtained two Paycheck
Protection Program loans for $295,745 and $295,745 that may be forgiven under the CARES Act,
if we can demonstrate that the proceeds from the loan were used for eligible expenses. We also obtained loans from the Small
Business Administration in the amount of $299,900 in May 2020, as included in the proceeds above. In addition, for the years ended
December 31, 2021 and 2020, the Company received debt financing of $8,090,000 and $735,000 through the operations of Viva Wealth
Fund I, LLC, which debt converts into Viva Wealth Fund I units at the earlier of 6 months or the minimum raise of $6,250,000 to
build a Remediation Processing Center (“RPC”) system. As of December 31, 2021, $5,560,000 of this debt financing has converted to noncontrolling units in Viva Wealth
Fund I, LLC. We believe we have other liquid assets that may be used to assist in financing the operations of the Company if needed,
including marketable securities in Scepter, which hold a fair value $2,231,218 as of December 31, 2021 and have been deposited for
trading. Subsequent to December 31, 2021, the Company closed its underwritten public offering of 1,600,000 shares of common stock,
at a public offering price of $5.00 per share, for aggregate gross proceeds of $8 million, prior to deducting
underwriting discounts, commissions, and other offering expenses. We believe the liquid assets from the Company’s available
for sale investments and funding provided from subsequent fundraising activities of the Company give it adequate working capital to
finance our day-to-day operations for at least twelve months through March 2023.
Note 3. Summary of Significant Accounting Policies
Basis of Presentation
The accompanying consolidated financial statements
have been prepared in accordance with the Financial Accounting Standards Board (“FASB”) “FASB Accounting Standard
Codification™” (the “Codification”) which is the source of authoritative accounting principles recognized
by the FASB to be applied by nongovernmental entities in the preparation of consolidated financial statements in conformity with generally
accepted accounting principles (“GAAP”) in the United States.
All figures are in U.S. dollars unless indicated
otherwise.
Principles of Consolidation
The consolidated financial statements include
the accounts of Vivakor, Inc., its wholly owned and majority-owned active subsidiaries, or joint ventures (collectively, the “Company”).
Intercompany balances and transactions between consolidated entities are eliminated. Inactive entities have no value, assets or liabilities.
Vivakor has the following wholly and majority-owned subsidiaries: Vivaventures Management Company, Inc., Vivaventures Energy Group, Inc.
(99%), Vivaventures Oil Sands, Inc., Vivasphere, Inc.. Vivakor Middle East, LLC (49%, consolidated). The Company withdrew from VivaVentures
Precious Metal, LLC (39%, equity method investment) in July 2020. Vivakor manages and consolidates RPC Design and Manufacturing LLC, which
includes a noncontrolling interest investment from Vivaopportunity Fund, LLC, which is also managed by Vivaventures Management Company,
Inc. Vivakor has common officers with and consolidates Viva Wealth Fund I, LLC.
The Company follows ASC 810-10-15 guidance with
respect to accounting for Variable Interest Entities (“VIE”). A VIE is an entity that does not have sufficient equity at risk
to finance its activities without additional subordinated financial support from other parties, or whose equity investors lack any of
the characteristics of a controlling financial interest. A variable interest is an investment or other interest that will absorb portions
of a VIE’s expected losses or receive portions of the entity’s expected residual returns. Variable interests are contractual,
ownership, or other pecuniary interests that change with changes in the fair value of the entity’s net assets. A party is the primary
beneficiary of a VIE and must consolidate it when that party has a variable interest, or combination of variable interests, that provides
the party with a controlling financial interest. A party is deemed to have a controlling financial interest if it meets both of the power
and losses/benefits criteria. The power criterion is the ability to direct the activities of the VIE that most significantly impact its
economic performance. The losses/benefits criterion is the obligation to absorb losses from, or right to receive benefits from, the VIE
that could potentially be significant to the VIE. The VIE model requires an ongoing reconsideration of whether a reporting entity is the
primary beneficiary of a VIE due to changes in facts and circumstances. For the years ended December 31, 2021 and 2020 the following entities
are considered to be a VIE and are consolidated in our consolidated financial statements: Viva Wealth Fund I, LLC (organized in 2020)
and RPC Design and Manufacturing, LLC. For the years ended December 31, 2021 and 2020 the following entities were considered to be a VIE,
but were not consolidated in our consolidated financial statements due to a lack of the power criterion or the losses/benefits criterion:
Vivaventures UTS I, LLC, Vivaventures Royalty II, LLC, Vivaopportunity Fund, LLC, and International Metals Exchange, LLC. For the years
ended December 31, 2021 and 2020 the unaudited financial information for the unconsolidated VIEs is as follows: Vivaventures UTSI, LLC
held assets of $3,753,296 and $3,113,292 (where the primary asset represents a receivable from the Company), and liabilities of $12,608
and $41,894. Vivaventures Royalty II, LLC held assets of $2,648,810 and $2,117,066 (where the primary asset represents a receivable from
the Company), and liabilities of $300. Vivaopportunity Fund LLC held assets of $2,119,961 (where the primary asset represents a noncontrolling
interest in units of a consolidated entity of the Company) and no liabilities. International Metals Exchange, LLC held assets of $30,461
and $82,711 and liabilities of $1,900.
RPC Design and Manufacturing, LLC: The
Company established RPC Design and Manufacturing, LLC (“RDM”) in December 2018 with a business purpose of manufacturing custom
machinery and selling or leasing the manufactured equipment in long term contracts with financing or leasing activities to the Company.
We own 100% of the voting rights in RDM. We, as the sole general partner of RDM, have the full, exclusive and complete right, power and
discretion to operate, manage and control the affairs of RDM and take certain actions necessary to maintain RDM in good standing without
the consent of the limited partners. RDM has entered into a license agreement with the Company indicating that while RDM builds custom
machinery incorporating the Company’s hydrocarbon extraction technology, RDM will pay the Company a license fee of $500,000 per
Remediation Processing Center manufactured. RDM has been retained by VWFI to assist in being the plant manager and will manage and direct the manufacturing
of the RPCs. RDM’s license fee is waived for RPC manufacturing for VWFI. Creditors of RDM have no recourse to the general credit
of the Company. For the years ended December 31, 2021 and 2020, investors in RDM have a noncontrolling interest of $629,694 and $1,343,018,
respectively As of December 31, 2021 and 2020,
the cash and cash equivalents of this VIE are not restricted and can be used to settle the obligations of the reporting entity. As of
December 31, 2021 and 2020 this VIE has an outstanding note payable to the reporting entity in the amount of $354,566 and $335,208, which
is eliminated upon consolidation. We have the primary risk (expense) exposure in financing and operating the assets and are responsible
for 100% of the operation, maintenance and any unfunded capital expenditures, which ultimately could be 100% of a custom machine, and
the decisions related to those expenditures including budgeting, financing and dispatch of power. Based on all these facts, it was determined
that we are the primary beneficiary of RDM. Therefore, RDM has been consolidated by the Company. Any intercompany revenue and expense
associated with RDM and its license agreement with the Company has been eliminated in consolidation.
Viva Wealth Fund I, LLC: The
Company assisted in designing and organizing Viva Wealth Fund I, LLC (“VWFI”) in November 2020, as a special purpose
entity, for the purpose of manufacturing, leasing and selling custom equipment solely to the Company. The Company commenced
co-managing VWFI with Wealth Space, LLC, an unaffiliated entity, but as of the date of this report Wealth Space, LLC is the sole
manager. The Company has been retained by the manager and continues to have common officers with VWFI, including our CEO and CFO,
who will assist in the day-to-day operations. VWFI has also retained the Company to act as its sole plant manager, and we will
manage and direct all of the manufacturing, leasing and selling of custom equipment in behalf of VWFI to the Company. In November
2020, VWFI commenced a $25,000,000 private placement offering to sell convertible promissory notes, which convert to VWFI LLC units,
to accredited investors to raise funds to manufacture equipment that will expand the Company’s second RPC. As of December 31,
2021 and 2020, the cash and cash equivalents of this VIE are restricted solely for the use of proceeds of the VWFI offering (to
manufacture RPCs) and cannot be used to settle the obligations of the reporting entity. As of December 31, 2021 and 2020, the
Company has cash attributed to variable interest entities of $199,952
and $89,500.
As of December 31, 2021, VWFI has reached $6,250,000 in funding and has released the funding for construction of RPC Series A. VWFI
has commenced fundraising for RPC Series B. In the event that VWFI does not raise at least $6,250,000 for these RPC Series by the
offering termination date (which date has been extended until November 13, 2022), then the convertible notes and/or units would
convert into Vivakor common stock where the minimum conversion price will be the greater of $13.50 or a 10% discount to
market per share or in the event of a public offering, 200% of the per share price of the Company common stock sold in the
underwritten offering, which was closed on February 14, 2022 at $5.00 per share. As of March 21, 2022, VWFI has raised approximately
$2,740,000 for RPC Series B. VWFI unit holders may also sell their units to the Company for their principal investment amount on the
3rd, 4th, and 5th anniversary of the offering termination date. The Company also has the option to
purchase any LLC units where the members did not exercise their conversion option under the same terms and pricing for cash or
common stock. VWFI has entered into a license agreement with the Company indicating that VWFI will pay the Company a license fee of
$1,000,000 per series of equipment manufactured with the Company’s proprietary technology. All of the operations of VWFI
relate to private placement offering to fund and manufacture proprietary equipment for the Company, as intended in VWFI’s
design and organization by the Company, so that the Company controls VWFI in its business purpose, use of proceeds, and selling and
leasing of its equipment solely to the Company. Creditors of VWFI have no recourse to the general credit of the Company. We have the
primary risk (expense) exposure in financing and operating the assets and are responsible for 100% of the operation, and any
unfunded capital expenditures, and the expense to the unit holders in conversion to common stock if series of equipment cannot be
fully funded, which ultimately could be 100% of any custom machine. We are responsible for the decisions related to the expenditures
of VWFI proceeds including budgeting, financing and dispatch of power surrounding the series of equipment. Based on all these facts,
it was determined that we are the primary beneficiary of VWFI. Therefore, VWFI has been consolidated by the Company.
Cash and Cash Equivalents
The Company considers all highly liquid
investments with an original maturity of three months or less when acquired to be cash equivalents. As of December 31, 2021 and
2020, the Company does not have any cash equivalents. The Company places its cash with high credit quality financial institutions.
The Company’s accounts at these institutions are insured by the Federal Deposit Insurance Corporation (“FDIC”) up
to $250,000. As of December 31, 2021 and 2020, the Company had bank balances exceeding the FDIC insurance limit. To reduce its risk
associated with the failure of such financial institutions, the Company annually evaluates the rating of the financial institutions
in which it holds deposits. As of December 31, 2021 and 2020, the Company has cash attributed to variable interest entities of
$199,952
and $89,500. The Company has $2,666 in Qatar National Bank, located in Doha Qatar.
Accounts Receivable
Accounts receivable are carried at original invoice
amount less an estimated allowance for doubtful accounts, if deemed necessary by management, and based on a review of all outstanding
amounts on a monthly basis. Management determines the allowance for doubtful accounts, if any, by identifying troubled accounts and by
using historical experience applied to an aging of accounts. An allowance for doubtful accounts was considered necessary by management
as of December 31, 2021 and 2020 in the amount of $33,000, respectively.
Investments
Consolidated net income includes the Company’s
proportionate net income or loss of equity investments. The carrying value of the Company’s equity method investments is increased
and decreased by the Company’s proportionate share of the net income or loss of the investee. The carrying value of our equity method
investment is also decreased by dividends the Company receives from the investee. The Company did not have any equity method investments
as of December 31, 2021. As of December 31, 2020 the equity method investments consisted of the following:
In 2019 the Company had an investment of
$800,000 or 800,000,000 shares of common stock, or a diluted 23% equity holding in Scepter Holdings, Inc. (ticker: BRZL, OTC
Markets) In the fourth quarter of 2020, the Company was diluted to a 19% equity holding in Scepter Holdings, Inc., and was no longer
deemed to have significant influence and ceased to be an equity investment, and as the stock is traded on an active market, the
Company has classified the investment as trading securities for the years ended December 31, 2021 and 2020 with the change in
unrealized gains and losses on the investment included in the statement of operations (see Note 5). For the year ended December 31,
2020, the Company was attributed a loss on this equity investment in the amount of $37,665.
There were no distributions to the Company in 2021 or 2020 from Scepter Holdings, Inc. As of December 31, 2020, the Company’s
Chief Executive Officer has an immediate family member who sits on the board of directors of Scepter Holdings, Inc. The
Company’s 826,376,882
shares of common stock of Scepter Holdings, Inc. have a market value of approximately $3,553,241
as of April 5, 2022 based on the quoted market price.
Investments in marketable securities consist of
equity securities recorded at fair value. Fair value is defined as the price that would be received to sell an asset in an orderly transaction
between market participants at the measurement date. We analyze our marketable securities in accordance with Accounting Standard Codification
321 (“ASC 321”). Valuations for marketable securities are based on quoted prices for identical assets in active markets.
As of December 31, 2019, the Company held a 39%
interest in Vivaventures Precious Metals, LLC for which the fair value of this investment was none. In July 2020, the Company withdrew
from this LLC.
As of December 31, 2021 and 2020, the Company
owns 1,000 Class A LLC Units in each of the following entities, which are not consolidated: Vivaopportunity Fund LLC, Vivaventures UTSI,
LLC, Vivaventures Royalty II, LLC, and International Metals Exchange, LLC. In aggregate these units amount to $4,000 as of December 31,
2021 and 2020. These Class A Units give the Company’s management control of the entities but lack the necessary economics criterion,
where the Company lacks the obligation to absorb losses of these entities, as well as the right to receive benefits from the LLCs.
Convertible Instruments
The Company reviews the terms of convertible debt
and preferred stock for indications requiring bifurcation, and separate accounting for the embedded conversion feature. Generally, embedded
conversion features where the ability to physical or net-share settle the conversion option is not within the control of the Company or
the number of shares is variable are bifurcated and accounted for as derivative financial instruments. (See Derivative Financial Instruments
below). Bifurcation of the embedded derivative instrument requires the allocation of the proceeds first to the fair value of the embedded
derivative instrument with the residual allocated to the host instrument. The resulting discount to the debt instrument or the redemption
value of convertible preferred securities is accreted through periodic charges to interest expense over the term of the agreements or
to dividends over the period to the earliest conversion date using the effective interest rate method, respectively.
Derivative Financial Instruments
The Company does not use derivative financial
instruments to hedge exposures to cash-flow or market risks. However, certain other financial instruments, such as warrants to purchase
the Company’s common stock and the embedded conversion features of debt and preferred instruments that are not considered indexed
to the Company’s common stock are classified as liabilities when either (a) the holder possesses rights to net-cash settlement,
(b) physical or net share settlement is not within the control of the Company, or (c) based on its anti-dilutive provisions. In such instances,
net-cash settlement is assumed for financial accounting and reporting. Such financial instruments are initially recorded at fair value
and subsequently adjusted to fair value at the close of each reporting period. Fair value for embedded conversion features and option-based
derivative financial instruments is determined using the Monte Carlo Simulation or the Black-Scholes Option Pricing Model, respectively.
Other convertible instruments that are not derivative
financial instruments are accounted for by recording the intrinsic value of the embedded conversion feature as a discount from the initial
value of the instrument and accreting it back to face value over the period to the earliest conversion date using the effective interest
rate method.
Leases
The Company follows Accounting Standards Codification
842, Leases ("ASC 842"). We determine if an arrangement contains a lease at inception based on whether or not the Company
has the right to control the asset during the contract period and other facts and circumstances.
We are the lessee in a lease contract when we
obtain the right to control the asset. Operating lease right-of-use ("ROU") assets represent our right to use an underlying
asset for the lease term, and lease liabilities represent our obligation to make lease payments arising from the lease, both of which
are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date. Leases with
a lease term of 12 months or less at inception are not recorded on our consolidated balance sheet and are expensed on a straight-line
basis over the lease term in our consolidated statement of operations. We determine the lease term by assuming the exercise of renewal
options that are reasonably certain. As most of our leases do not provide an implicit interest rate, we use our local incremental borrowing
rate based on the information available at the commencement date in determining the present value of future payments. As of December 31,
2021 and 2020, we recorded right-of-use assets of $663,291 and $881,804 and lease obligations of $721,878 and $895,395.
Long Lived Assets
The Company reviews the carrying values of its
long-lived assets for possible impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.
If the expected future cash flow from the use of the asset and its eventual disposition is less than the carrying amount of the asset,
an impairment loss is recognized and measured using the fair value of the related asset. No impairment charges were incurred during the
years ended December 31, 2021 and 2020, as the Company was still in the early phases of our business
plan and operating losses were expected in our early phases. On March 11, 2020, the World Health Organization (“WHO”)
declared the COVID-19 outbreak to be a global pandemic. In addition to the devastating effects on human life, the pandemic is having a
negative ripple effect on the global economy, leading to disruptions and volatility in the global financial markets. Most U.S. states
and many countries have issued policies intended to stop or slow the further spread of the disease. Our Kuwait operations were suspended
to comply with the social distancing measures implemented in Kuwait. Our Utah operations were temporarily suspended from March through
May 2020, but have since resumed in full. There can be no assurance, however, that market conditions will not change or demand for the
Company’s services will continue, which could result in impairment of long-lived assets in the future.
Property and equipment, net
Property and equipment are stated at cost or fair
value when acquired. Depreciation is computed by the straight-line method and is charged to the statement of operations over the estimated
useful lives of the assets. Leasehold improvements are depreciated over the shorter of the estimated useful lives of the assets or the
term of the related lease. Impairment losses are recognized for long-lived assets, including definite-lived intangibles, used in operations
when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are not sufficient
to recover the assets' carrying amount. Impairment losses are measured by comparing the fair value of the assets to their carrying amount.
Interest on long-term debt for the development
or manufacturing of Company assets is capitalized to the asset until the asset enters production or use, and thereafter all interest is
charged to expense as incurred. Maintenance and repairs are charged to expense as incurred. Leasehold improvements are depreciated over
the shorter of the estimated useful lives of the assets or the term of the related lease.
The carrying amount and accumulated depreciation
of assets sold or retired are removed from the accounts in the year of disposal and any resulting gain or loss is included in results
of operations. The estimated useful lives of property and equipment are as follows:
Schedule of useful lives for property plant
and equipment |
|
Computers, software, and office equipment |
1-5 years |
Machinery and equipment |
3-5 years |
Vehicles |
5 years |
Furniture and fixtures |
5 – 10 years |
Precious metal extraction machinery (heavy extraction equipment) |
10 years |
Remediation Processing Centers (heavy extraction and remediation equipment) (“RPC”) |
20 years |
Leasehold improvements |
Lesser of the lease term or estimated useful life |
Equipment that is currently being manufactured
is considered construction in process and is not depreciated until the equipment is placed into service.
Intangible Assets:
We account for intangible assets in accordance
with ASC 350 “Intangibles-Goodwill and Other” (“ASC 350”). Intangible asset amounts represent the acquisition
date fair values of identifiable intangible assets acquired. The fair values of the intangible assets were determined by using the income
approach, discounting projected future cash flows based on management’s expectations of the current and future operating environment.
The rates used to discount projected future cash flows reflected a weighted average cost of capital based on our industry, capital structure
and risk premiums including those reflected in the current market capitalization. Definite-lived intangible assets are amortized over
their useful lives, which have historically ranged from 10 to 20 years. The carrying amounts of our definite-lived intangible assets are
evaluated for recoverability whenever events or changes in circumstances indicate that the entity may be unable to recover the asset’s
carrying amount.
We assess our intangible assets in accordance
with ASC 360 “Property, Plant, and Equipment” (“ASC 360”). Impairment testing is required when events occur
that indicate an asset group may not be recoverable (“triggering events”). As detailed in ASC 360-10-35-21, the following
are examples of such events or changes in circumstances (sometimes referred to as impairment indicators or triggers): (a) A significant
decrease in the market price of a long-lived asset (asset group) (b) A significant adverse change in the extent or manner in which a long-lived
asset (asset group) is being used or in its physical condition. (c) A significant adverse change in legal factors or in the business climate
that could affect the value of a long-lived asset (asset group), including an adverse action or assessment by a regulator (d) An accumulation
of costs significantly in excess of the amount originally expected for the acquisition or construction of a long-lived asset (asset group)
(e) A current-period operating or cash flow loss combined with a history of operating or cash flow losses or a projection or forecast
that demonstrates continuing losses associated with the use of a long-lived asset (asset group) (f) A current expectation that, more likely
than not, a long-lived asset (asset group) will be sold or otherwise disposed of significantly before the end of its previously estimated
useful life. The term more likely than not refers to a level of likelihood that is more than 50 percent. We have evaluated our intangible
assets and found that certain losses and a delay in our business plan may have constituted a triggering event for our intangible assets.
We performed an analysis and assessed that there to be no impairment for the years ended December 31, 2021 and 2020.
Share-Based Compensation
Share-based compensation is accounted for based
on the requirements of ASC 718, “Compensation-Stock Compensation’ (“ASC 718”) which requires recognition in the
financial statements of the cost of employee, consultant, or director services received in exchange for an award of equity instruments
over the period the employee, consultant, or director is required to perform the services in exchange for the award (presumptively, the
vesting period). ASC 718 also requires measurement of the cost of employee, consultant, or director services received in exchange for
an award based on the grant-date fair value of the award.
Income tax
Deferred income taxes are provided on the asset
and liability method whereby deferred income tax assets are recognized for deductible temporary differences and operating loss and tax
credit carryforwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences
between the reported amounts of assets and liabilities and their tax bases. Deferred income tax assets are reduced by a valuation allowance
when, in the opinion of management, it is more likely than not that some portion or all of the deferred income tax assets will not be
realized. Deferred income tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
Our annual effective tax rate is based on our
income and the tax laws in the various jurisdictions in which we operate. Judgment is required in determining our annual tax expense and
in evaluating our tax positions. We establish reserves to remove some or all of the tax benefit of any of our tax positions at the time
we determine that the position becomes uncertain based upon one of the following conditions: (1) the tax position is not "more likely
than not" to be sustained; (2) the tax position is "more likely than not" to be sustained, but for a lesser amount; or
(3) the tax position is "more likely than not" to be sustained, but not in the financial period in which the tax position was
originally taken. For purposes of evaluating whether or not a tax position is uncertain, (1) we presume the tax position will be examined
by the relevant taxing authority that has full knowledge of all relevant information; (2) the technical merits of a tax position are derived
from authorities such as legislation and statutes, legislative intent, regulations, rulings and case law and their applicability to the
facts and circumstances of the tax position; and (3) each tax position is evaluated without considerations of the possibility of offset
or aggregation with other tax positions taken. We adjust these reserves, including any impact on the related interest and penalties, in
light of changing facts and circumstances, such as the progress of a tax audit. See Note 20 for further information on income tax.
Revenue Recognition
We follow Accounting Standards Codification 606,
Revenue from Contracts with Customers (“ASC 606”). For the year ended December 31, 2021 and 2020, approximately 99% and 96%
of our sales consist of the sale of precious metals with a commitment to deliver precious metals to the customer, and revenue
is recognized on the settlement date, which is defined as the date on which: (1) the quantity, price, and specific items being purchased
have been established, (2) metals have been shipped to the customer, and (3) payment has been received or is covered by the customer’s
established credit limit with the Company.
The revenue standard contains a five-step approach that
entities will apply to determine the measurement of revenue and timing of when it is recognized, including (i) identifying the contract(s)
with a customer, (ii) identifying the separate performance obligations in the contract, (iii) determining the transaction price, (iv)
allocating the transaction price to separate performance obligations, and (v) recognizing revenue when (or as) each performance obligation
is satisfied. The new standard requires a number of disclosures intended to enable users of financial statements to understand the nature,
amount, timing and uncertainty of revenue, and the related cash flows. The disclosures include qualitative and quantitative information
about contracts with customers, significant judgments made in applying the revenue guidance, and assets recognized from the costs to obtain
or fulfill a contract.
In order to ensure the revenue recognition in
the proper period, we review material sales contracts for proper cut-off based upon the business practices and legal requirements of each
country.
Our performance obligation generally consists
of the promise to sell products or complete services to our customers. Control of the products is transferred upon shipment to our customers'
locations, as determined by the specific terms of the contract. Upon transfer of control to the customer, which completes our performance
obligation, revenue is recognized. Services are completed upon the terms of each contract, specifically in regard to remediation, when
the tonnage of contaminated soil is completed and tested our performance obligation is completed and revenue is recognized. After completion
of our performance obligation, we have an unconditional right to consideration as outlined in the contract. Historically, we have not
accepted returns so there are no sales allowances. Due to the nature of the product we do accept returns. Our receivables will generally
be collected in less than nine months, in accordance with the underlying payment terms.
Advertising Expense
Advertising
costs are expensed as incurred. The Company did not incur advertising expense for the years ended December 31, 2021 and 2020.
Recent Accounting Pronouncements
Under the Jumpstart Our Business Startups Act,
or the JOBS Act, we meet the definition of an “emerging growth company.” We have irrevocably elected to opt-out of the extended
transition period for complying with new or revised accounting standards pursuant to Section 107(b) of the JOBS Act. As a result,
we will comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-
emerging growth companies.
In June 2016, the Financial Accounting Standards
Board issued Accounting Standards Update 2016-13, or ASU 2016-13. ASU 2016-13 significantly changed how entities measured credit losses
for most financial assets and certain other instruments that are not measured at fair value through net income. ASU 2016-13 replaced the
incurred loss model under previous guidance with a current expected credit loss, or CECL. ASU 2016-13 was effective for fiscal years
beginning after December 15, 2019. The Company is anticipated to enter into scaled revenue producing activities in 2022 which
will generate accounts receivable which may require an evaluation of potential credit losses under the CECL standard.
In December 2019, the Financial Accounting Standards
Board ("FASB") issued Accounting Standards Update ("ASU") 2019-12, Simplifying the Accounting for Income Taxes,
which eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating taxes during
the quarters and the recognition of deferred tax liabilities for outside basis differences. This guidance also simplifies aspects of the
accounting for franchise taxes and changes in tax laws or rates, as well as clarifies the accounting for transactions that result in a
step-up in the tax basis of goodwill. ASU 2019-12 became effective for the Company beginning January 1, 2021.
In August
2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2020-06
Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own
Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which improves Convertible
Instruments and Contracts in an Entity’s Own Equity and is expected to improve financial reporting associated with accounting for
convertible instruments and contracts in an entity’s own equity. The ASU simplifies accounting for convertible instruments by removing
major separation models required under current U.S. GAAP. Consequently, more convertible debt instruments will be reported as a single
liability instrument and more convertible preferred stock as a single equity instrument with no separate accounting for embedded conversion
features. The ASU removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception,
which will permit more equity contracts to qualify for it. The ASU also simplifies the diluted earnings per share (EPS) calculation in
certain areas.
In May 2021, the Financial Accounting Standards
Board ("FASB") issued Accounting Standards Update ("ASU") 2021-04 Earnings Per Share (Topic 260), Debt— Modifications
and Extinguishments (Subtopic 470-50), Compensation—Stock Compensation (Topic 718), and Derivatives and Hedging— Contracts
in Entity’s Own Equity (Subtopic 815-40), provides a “principles-based framework to determine whether an issuer should
recognize the modification or exchange as an adjustment to equity or an expense.”
Net Income/Loss Per Share
Basic net income (loss) per share is
calculated by subtracting any preferred interest distributions from net income (loss), all divided by the weighted-average number of
common shares outstanding for the period, without consideration for common stock equivalents. Diluted net income (loss) per common
share is computed by dividing the net income (loss) by the weighted-average number of common share equivalents outstanding for the
period determined using the treasury stock method if their effect is dilutive. Potential dilutive instruments as of December 31,
2021 and 2020 include the following: convertible notes payable convertible into approximately 192,834 and 35,765 shares of common
stock, convertible Series A preferred stock convertible into none and 666,667 shares of common stock (in the event of a public
offering of the Company’s common stock this will convert to 833,333 shares), convertible Series B preferred stock convertible
into approximately none and 216,916 shares of common stock, convertible Series B-1 preferred stock convertible into approximately
none and 467,728 shares of common stock, convertible Series C-1 preferred stock convertible into approximately none and 255,290
shares of common stock, stock options granted to employees of 183,333 and 16,667 shares of common stock. Stock options granted to
Board members or consultants of 466,667 shares of common stock were granted as of December 31, 2021.
Use of Estimates
The preparation of financial statements in conformity
with accounting principles generally accepted in the United States of America requires management to make estimates, judgments, and assumptions
that affect the amounts reported in the consolidated financial statements and accompanying notes. We believe our critical accounting estimates
relate to the following: Recoverability of current and noncurrent Assets, revenue recognition, stock-based compensation, income taxes,
effective interest rates related to long-term debt, marketable securities, cost basis and equity method investments, lease assets and
liabilities, equity method investments, valuation of stock used to acquire assets, and derivatives.
While our estimates and assumptions are based
on our knowledge of current events and actions we may undertake in the future, actual results may ultimately differ from these estimates
and assumptions.
Fair Value of Financial Instruments
The Company follows Accounting Standards Codification
(“ASC”) 820, “Fair Value Measurements and Disclosures” (“ASC 820”), for assets and liabilities measured
at fair value on a recurring basis. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted
accounting principles that requires the use of fair value measurements, establishes a framework for measuring fair value, and expands
disclosure about such fair value measurements. The adoption of ASC 820 did not have an impact on the Company’s financial position
or operating results but did expand certain disclosures.
ASC 820 defines fair value as the price that would
be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement
date. Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of
unobservable inputs. These inputs are prioritized below:
Level 1: Applies to assets or liabilities for
which there are quoted prices in active markets for identical assets or liabilities.
Level 2: Applies to assets or liabilities for
which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets
or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent
transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally
from, or corroborated by, observable market data.
Level 3: Applies to assets or liabilities for
which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets
or liabilities.
The Company analyzes all financial instruments
with features of both liabilities and equity under the Financial Accounting Standard Board’s (“FASB”) accounting standard
for such instruments. Under this standard, financial assets and liabilities are classified in their entirety based on the lowest level
of input that is significant to the fair value measurement. The carrying amounts reported in the consolidated balance sheets for marketable
securities are classified as Level 1 assets due to observable quoted prices for identical assets in active markets. The carrying amounts
reported in the consolidated balance sheets for cash, prepaid expenses and other current assets, accounts payable and accrued expenses
approximate their estimated fair market values based on the short-term maturity of these instruments. The
recorded values of notes payable approximate their current fair values because of their nature, rates, and respective maturity dates or
durations.
Note 4. Prepaid Expenses and Other Assets
As of December 31, 2021 and 2020, our other assets
consist of various deposits with vendors, professional service agents, or security deposits on office and warehouse leases. As of December
31, 2021 and 2020 we had deposits in the amount of $73,245 and $87,052.
The Company entered into an Option Agreement in
July 2019 for the exclusive right to purchase certain real property commonly known as Asphalt Ridge. The right to purchase the land was
purchased for $200,000, which would be applied as a payment on the land if the option is exercised to purchase the land. The Company amortized
the prepaid over the life of the agreement, 12 months, and the option was completed amortized as of December 31, 2020. For the year ended
December 31, 2020 amortization expense was $117,891. In March 2022, the Company entered into a long term five year lease, with an extension
for an additional five year term, in order to operate on the land.
Note 5. Marketable Securities
Investments in marketable securities consist of
equity securities recorded at fair value. Fair value is defined as the price that would be received to sell an asset in an orderly transaction
between market participants at the measurement date. We analyze our marketable securities in accordance with Accounting Standard Codification
321 (“ASC 32”). Valuations for marketable securities are based on quoted prices for identical assets in active markets. Where
marketable securities were found not be part of an actively traded market, we made a measurement alternative election and estimate the
fair value at cost of the investment minus impairment.
As of December 31, 2020, the Company owned 3,309,758
shares of common stock in Odyssey Group International, Inc. (“Odyssey”) ticker: ODYY, OTC Markets. In December 2021
we sold such shares of Odyssey in a private transaction for a purchase price of $860,491,
with $10,000 cash delivered at signing and a note issued in favor of Vivakor in the amount of $850,491 (see Note 8), reflecting the market
price at that time. The Company accounted for such securities based on the quoted price from the OTC Markets where the stock is traded
which resulted in the Company recording an unrealized gain of $203,540
and an unrealized loss of $56,198
on these marketable securities for the years ended December 31, 2020. As of December 31, 2020 our Odyssey marketable securities
were valued at $656,951.
In 2019 the Company had an investment of
$800,000
or 800,000,000
shares of common stock, or a diluted 23% equity holding in Scepter Holdings, Inc. (“Scepter”), ticker: BRZL, OTC
Markets. In the fourth quarter of 2020, the Company was diluted to a 19% equity holding in Scepter, and was no longer deemed to have
significant influence and ceased to be an equity investment, and as the stock is traded on an active market, the Company has
classified the investment as marketable securities with the change in unrealized gains and losses on the investment included in the
statement of operations for the years ended December 31, 2021 and 2020. In August 2021 we converted $81,768
of our note receivable with Scepter into 26,376,882
shares of Scepter common stock pursuant to the terms of the note at $0.0031 per share. On the date of the conversion, the Scepter
price per share on OTC Markets was $0.0062 per share, which resulted in a $87,044
gain on the disposition of the note receivable. The Company accounted for such securities based on the quoted price from the OTC
Markets where the stock is traded which resulted in the Company recording an unrealized loss on marketable securities of $1,297,594
and and an unrealized gain of $2,670,536
for the years ended December 31, 2021 and 2020. As of December 31, 2021 and 2020, the Company’s Chief Executive Officer has an
immediate family member who sits on the board of directors of Scepter Holdings, Inc. As of December 31, 2021 and 2020 our Scepter
marketable securities were valued at $2,231,218
and $3,360,000.
As of December 31, 2021 and 2020, marketable securities
were $2,231,218 and $4,016,951. For the years ended December 31, 2021 and 2020, the Company recorded a total unrealized loss of $1,094,054
and an unrealized gain of $2,614,338 on marketable securities in the statement of operations.
Note 6. Inventories
As of December 31, 2020, inventories consist
primarily of raw materials (including tar-sand stockpiles) and finished goods (which includes Fenix iron). The tar-sand stockpiles
consist of 400,000 tons of tar sand stockpile and are anticipated to be used as test material for our extraction remediation units.
The stockpiles were acquired at a cost of approximately $0.83 per ton or $333,744.
As of December 31, 2021, the parties agreed to have the $333,744 paid for the tar-sand stockpile returned to the Company, and the
amount has been reclassed to notes receivable (see Note 8). The nano Fenix Iron are finished goods that have a 20-year shelf life
and were acquired at cost for $192,000.
As of December 31, 2021, inventories consist primarily of the Fenix Iron. Inventories are valued at the lower of cost or market (net
realizable value).
Note 7. Precious Metal Concentrate
Precious metal concentrate includes metal concentrates
located at the Company’s facilities. Concentrates consist of gold, silver, platinum, palladium, and rhodium. Precious metal concentrate
was acquired from our funding agreements for extraction operations with Vivaventures Precious Metals LLC from 2013 through 2016. Our precious
metal concentrate requires further refining to be sold as a finished product and is valued at the lower of cost or market (net realizable
value).
As of December 31, 2021 and 2020, the Company
carried a refining reserve of $1,166,709 against its
precious metal concentrate asset based on estimates that the Company received if it were to sell the precious metal concentrate in its
current concentrated form to processing refineries. The Company intends to sell our precious metal concentrate in its current state or
refine it into dore bars for sale or monetization and investment purposes. In July 2020, the Company entered into an agreement with International
Metals Exchange, LLC (“IME”, a related party) giving IME the option to purchase approximately 1,331 ounces of our precious
metal concentrate for approximately $2,800,000. The option agreement expired on December 31, 2020. For the year ended December 31, 2020,
the Company sold $54,250
of the precious metal concentrate through this option.
As of December 31, 2021 and 2020 the net realizable
value of our precious metal concentrate is $1,166,709.
Note
8. Notes Receivable
Schedule Of notes receivable | |
| | | |
| | |
| |
December 31, | |
| |
2021 | | |
2020 | |
Scepter Holdings, Inc. note receivable (a) | |
| – | | |
| 78,455 | |
PLC International Investments, Inc. (b) | |
| 860,491 | | |
| – | |
TMC Capital, LLC (c) | |
| 333,744 | | |
| – | |
Total Notes Receivable | |
$ | 1,194,235 | | |
$ | 78,455 | |
______________________
(a) |
Master Revolving Note with Scepter Holdings, Inc. (ticker: BRZL, OTC Markets), which the Company entered into in January 2019 to lend
up to $70,000 to the holder. The note accrues interest at a rate of 7% per annum and accrues monthly on the outstanding principal. In
August 2021 we converted the note receivable with Scepter into 26,376,882 shares of Scepter common stock pursuant to the terms of the
note at $0.0031 per share. On the date of the conversion, the Scepter price per share on OTC Markets was $0.0062 per share, which resulted
in a $87,044 gain on the disposition of the note receivable. |
(b) |
In December 2021 we sold such 3,309,578 shares of Odyssey common stock in a private transaction for a purchase price of $860,491, reflecting
the market price as of such time. Such purchase price was paid in the form of $10,000 cash delivered at signing and a note issued in
favor of Vivakor in the amount of $850,491 accruing interest at 3% per annum, with payments due quarterly over a five year term. |
(c) |
The Company entered into an Ore Supply Agreement in December 2016 with TMC Capital, LLC, an affiliate of MCW Energy Group Limited, in
which the Company had the option to purchase 400,000 tons of oil sands from the supplier. The Company paid the supplier $333,744 at the
commencement of the agreement. The parties amended the agreement in December 2021 to return the $333,744 on or before October 1, 2022. |
Note 9. Property and Equipment
The following table sets forth the components
of the Company’s property and equipment at December 31, 2021 and 2020:
Schedule of property and equipment,
net | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
December 31, 2021 | | |
December 31, 2020 | |
| |
Gross Carrying Amount | | |
Accumulated Depreciation | | |
Net Book Value | | |
Gross Carrying Amount | | |
Accumulated Depreciation | | |
Net Book Value | |
| |
| | |
| | |
| | |
| | |
| | |
| |
Office furniture and equipment | |
$ | 14,998 | | |
$ | 4,000 | | |
$ | 10,998 | | |
$ | 14,998 | | |
$ | 2,088 | | |
$ | 12,910 | |
Vehicles | |
| 48,248 | | |
| 26,306 | | |
| 21,942 | | |
| 48,248 | | |
| 16,657 | | |
| 31,591 | |
Precious metal extraction machine- 1 ton | |
| 2,280,000 | | |
| 228,000 | | |
| 2,052,000 | | |
| 2,280,000 | | |
| 228,000 | | |
| 2,052,000 | |
Precious metal extraction machine- 10 ton | |
| 5,320,000 | | |
| 532,000 | | |
| 4,788,000 | | |
| 5,320,000 | | |
| 532,000 | | |
| 4,788,000 | |
| |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Construction in process: | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Bioreactors | |
| 1,440,000 | | |
| – | | |
| 1,440,000 | | |
| 1,440,000 | | |
| – | | |
| 1,440,000 | |
Nanosponge/Cavitation device | |
| 22,103 | | |
| – | | |
| 22,103 | | |
| 22,103 | | |
| – | | |
| 22,103 | |
Remediation Processing Unit 1 | |
| 6,249,082 | | |
| – | | |
| 6,249,082 | | |
| 5,558,949 | | |
| – | | |
| 5,558,949 | |
Remediation Processing Unit 2 | |
| 5,201,098 | | |
| – | | |
| 5,201,098 | | |
| 4,149,793 | | |
| – | | |
| 4,149,793 | |
Remediation Processing Unit System A | |
| 2,561,467 | | |
| – | | |
| 2,561,467 | | |
| 97,353 | | |
| – | | |
| 97,353 | |
Remediation Processing Unit System B | |
| 2,345,421 | | |
| – | | |
| 2,345,421 | | |
| – | | |
| – | | |
| – | |
Total fixed assets | |
$ | 25,482,417 | | |
$ | 790,306 | | |
$ | 24,692,111 | | |
$ | 18,931,444 | | |
$ | 778,745 | | |
$ | 18,152,699 | |
For the year ended December 31, 2021 the Company
paid $64,950 with 5,413 shares of Series C-1 Preferred Stock for equipment, which has been valued based on similar cash purchases of the
Series C-1 Preferred Stock at approximately $12.00 per share. For the years ended December 31, 2021 and 2020 depreciation expense was
$11,561 and $11,508. For the years ended December 31, 2021 and 2020 capitalized interest to equipment from debt financing was $1,614,697
and $1,025,852. Equipment that is currently being manufactured is considered construction in process and is not depreciated until the
equipment is placed into service. Equipment that is temporarily not in service is not depreciated until placed into service.
Note 10. License Agreements
On August 17, 2017, the Company purchased rights
to an exclusive license for the applications and implementations involving the Nanosponge Technology and to use and develop the Nanosponge
as we see fit at our sole discretion. The Nanosponge contribution in the Company’s processes is to facilitate a cracking process
whereby remediated or extracted oil may be further refined from a crude product to a diesel fuel. The license was valued at $2,416,572
and is amortized over its useful life of 20 years. As of December 31, 2021 and 2020 the accumulated amortization of the license was $523,591
and $402,762. For the years ended December 31, 2021 and 2020 amortization expense of the license was $120,829. Amortization expense for
the years 2022 through 2026 is $120,829 in each respective year. As of December 31, 2021 and 2020 the net value of the license is $1,892,981
and $2,013,810.
On January
20, 2021, the Company entered into a worldwide, exclusive license agreement with TBT Group, Inc. (of which an independent Vivakor Board
member is a 7% shareholder) to license piezo electric and energy harvesting technologies for creating self-powered sensors for making
smart roadways. The Company is required to pay $25,000 and 16,667 shares of restricted common stock upon signing. No later than
March 4, 2022, the Company will pay licensor an additional $225,000. When the licensor delivers to the Company data showing that the sensor
performs based on mutually defined specifications and all designs for the sensor are completed, Company shall pay an additional $250,000
and 16,667 shares of restricted common stock. Upon the delivery of a mutually agreed working prototype, Company will pay licensor $250,000
and 16,667 shares of restricted common stock. Upon commercialization of the product, the Company will pay licensor $250,000 and 33,333
shares of restricted common stock. TBT shall have the option, at its sole discretion, to convert the license to a non-exclusive license
if the Company fails to pay $500,000 to TBT for sensor inventory per year, which will commence after the second anniversary of product
commercialization. The Company shall share in the development costs of the sensor technology to the time of commercialization. Total costs
attributed to the Company are estimated to be $125,000. The Company amended the agreement multiple times in 2021 to extend the terms of
the first milestone payment of $225,000 payment to the licensor, and further amended the agreement in March 2022 to finally extend the
payment to be no later than March 4, 2022. The Company paid consideration of $15,000 for these amended extensions.
As of December 31, 2021, the license is valued
at $490,000 (or each of the initial required payments in milestone one and a $15,000 additional payment) and is amortized over its useful
life of 20 years. As of December 31, 2021 the Company believes that the remaining milestones timelines are undetermined. As of December
31, 2021, the accumulated amortization of the license was $12,146. For the year ended December 31, 2021 amortization expense of the license
was $12,146. Amortization expense for the years 2022 through 2026 is $13,250 in each respective year. As of December 31, 2021 the net
value of the license is $477,854.
Note 11. Intellectual Property, Net
The Company entered into a Contribution Agreement
dated January 5, 2015, where proprietary information and intellectual property related to certain petroleum extraction technology (also
known as hydrocarbon extraction technology) suitable to extract petroleum (or hydrocarbons) from tar sands and other sand-based ore bodies,
and all related concepts and conceptualizations thereof (the “Extraction Technology”) was contributed to VivaVentures Energy
Group, Inc., a 99% majority-owned subsidiary of Vivakor, and was assessed a fair market value of $16,385,157, which consists of the consideration
of $11,800,000 and the Company assuming a deferred tax liability in the amount of $4,585,157. All ownership in the Extraction Technology
(including all future enhancements, improvements, modifications, supplements, or additions to the Extraction Technology) was assigned
to the Company and is currently being applied to the Company Remediation Processing Centers, which are the units that remediate material.
The Extraction Technology is amortized over a 20-year life. For the years ended December 31, 2021
and 2020 the amortization expense of the technology was $819,258. Amortization expense for the years 2022 through 2026 is $819,258
in each respective year. As of December 31, 2021 and 2020 the net value of the Extraction Technology is $10,718,623 and $11,537,881.
In 2019, the Company began the process of patenting
the Extraction Technology and all of its developments and additions since the acquisition, and we have filed a series of patents and
capitalized the costs of these patents. As of December 31, 2021 and 2020, the capitalized costs of these patents are $113,430 and $100,064.
The patents were placed in service in 2021 and are amortized over the patents’ useful life of twenty years. For
the year ended December 31, 2021 the amortization expense of the patents was $5,560. Amortization expense for the years 2022 through
2026 is $5,672 in each respective year. As of December 31, 2021 the net value of the patents is $107,870.
The Company entered into an asset purchase agreement
dated September 5, 2017, where two patents (US patent number 7282167- Method and apparatus for forming
nano-particles and US patent number 9272920- System and method for ammonia synthesis)
were purchased and attributed a fair market value of $4,931,380, which consists of the consideration of $3,887,982 and the Company assuming
a deferred tax liability in the amount of $1,043,398. The patents grant the Company ownership of a nano catalyst technology that facilitates
chemical manufacturing, with a focus on the production of ammonia, specifically for the gas phase
condensation process used to create the iron catalyst. The nano catalyst accelerators make
the Haber-Bosch process more efficient by increasing the active surface area of standard commercial iron catalysts, thereby lowering the
reaction temperature and pressure required for the Haber-Bosch process to occur. As a result, less energy is needed to complete the reaction
and create ammonia. The patents are amortized over their useful life of 10 years. For the years ended December 31, 2021 and 2020 the amortization
expense of the patents was $369,854. Amortization expense for the years 2022 through 2026 is $493,138 in each respective year.
As of December 31, 2021 and 2020 the net value of the patents was $2,835,544 and $3,328,682.
The following table sets forth the components
of the Company’s intellectual property at December 31, 2021 2020:
Schedule Of Intellectual Property | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
December 31, 2021 | | |
December 31, 2020 | |
| |
Gross Carrying Amount | | |
Accumulated Amortization | | |
Net Book Value | | |
Gross Carrying Amount | | |
Accumulated Amortization | | |
Net Book Value | |
| |
| | |
| | |
| | |
| | |
| | |
| |
Extraction Technology patents | |
$ | 113,430 | | |
$ | 5,560 | | |
$ | 107,870 | | |
$ | 100,064 | | |
$ | – | | |
$ | 100,064 | |
Extraction Technology | |
| 16,385,157 | | |
| 5,666,534 | | |
| 10,718,623 | | |
| 16,385,157 | | |
| 4,847,276 | | |
| 11,537,881 | |
Ammonia synthesis patents | |
| 4,931,380 | | |
| 2,095,836 | | |
| 2,835,544 | | |
| 4,931,380 | | |
| 1,602,698 | | |
| 3,328,682 | |
Total Intellectual property | |
$ | 21,429,967 | | |
$ | 7,767,930 | | |
$ | 13,662,037 | | |
$ | 21,416,601 | | |
$ | 6,449,974 | | |
$ | 14,966,627 | |
Note 12. Accounts Payable and Accrued Expenses
Accounts payable and accrued expenses consist
of the following:
Schedule of accounts payable and accrued expenses | |
| | | |
| | |
| |
December 31, | |
| |
2021 | | |
2020 | |
Accounts payable | |
$ | 1,450,531 | | |
$ | 1,003,953 | |
Office access deposits | |
| 340 | | |
| 705 | |
Accrued compensation | |
| 175,000 | | |
| 101,920 | |
Accrued tax penalties and interest | |
| 398,114 | | |
| 244,230 | |
Accounts payable and accrued expenses | |
$ | 2,023,985 | | |
$ | 1,350,808 | |
Note 13. Stock Payable
As of December 31, 2019, the Company had an outstanding
payable of $11,800,000 payable in common stock to Sustainable Fuels, Inc. (“SFI”) for the Extraction Technology (See Note
11). Before the Common Stock was issued, the owner of SFI died and the matters and affairs of his estate were passed to the executor of
his estate. We attempted to contact SFI and the executor of the estate multiple times to issue and send the common stock to the company
or appropriate successor of the estate to no avail. As of December 31, 2021, the Company was able to make contact with the new owner of
SFI and has issued 20,000,000 shares of Common Stock to SFI per the terms of the agreement.
Note 14. Loans and Notes Payable
Loans and Notes payable (including accrued interest)
consist of the following:
Schedule of loans and notes payable | |
| | | |
| | |
| |
December 31, | |
| |
2021 | | |
2020 | |
Various promissory notes and convertible notes (a) | |
$ | 50,960 | | |
$ | 50,960 | |
Novus Capital Group LLC Note (b) | |
| 378,854 | | |
| 363,231 | |
Triple T Notes (c) | |
| 353,330 | | |
| 295,543 | |
National Buick GMC (d) | |
| 19,440 | | |
| 25,643 | |
Various Convertible Bridge Notes ( e) | |
| 1,075,813 | | |
| 774,522 | |
Blue Ridge Bank (f) | |
| 410,200 | | |
| 205,100 | |
Small Business Administration (g) | |
| 318,175 | | |
| 305,054 | |
JP Morgan Chase Bank (h) | |
| 90,645 | | |
| 90,645 | |
Various Promissory Notes (i) | |
| 3,416,379 | | |
| 735,000 | |
Total Notes Payable | |
$ | 6,113,796 | | |
$ | 2,845,698 | |
| |
| | | |
| | |
Loans and notes payable, current | |
$ | 1,511,447 | | |
$ | 1,196,037 | |
Loans and notes payable, current attributed to variable interest entity | |
| 3,416,379 | | |
| 735,000 | |
Loans and notes payable, long term | |
$ | 1,185,970 | | |
$ | 914,661 | |
_____________
Schedule of maturities of loans and notes payable | |
| | |
2022 | |
$ | 5,173,946 | |
2023 | |
| 406,326 | |
2024 | |
| 52,996 | |
2025 | |
| 52,996 | |
2026 | |
| 52,996 | |
Thereafter
| |
| 374,536 | |
Total | |
$ | 6,113,796 | |
(a) |
From 2013 through 2018 the Company issued a series of promissory notes and convertible notes with various interest rates ranging up to
12% per annum. The convertible notes convert at the holder’s option after 1 year of issuance and may be converted into shares of
common stock. The conversion price is generally equal to the specified per share conversion rate as noted in the note agreements. |
(b) |
On September 5, 2017, the Company acquired patents in the amount of $4,931,380 in which the Company also agreed to assume the encumbering
debt on asset in the amount of $334,775 due in December 2019 with no interest accruing until 2020 and a deferred tax liability of $1,043,398.
As of January 1, 2020 the note was amended to accrue interest at 7% per annum commencing January 1, 2020 through July 1, 2020, and 10%
per annum commencing July 2, 2020 and thereafter. In November 2021, the lender agreed to extend the maturity of the note to April 1,
2022. Subsequent to December 31, 2021 the lender agreed to extend the maturity of the note to April 1, 2023 with an approximate monthly
payment of $29,432. |
(c) |
The balance of this note is due to a related party, a company owned the
51% owner of Vivakor Middle East LLC. The loan was granted to Vivakor Middle East LLC by the majority owner for operational use with only
the agreement of repayment from the net proceeds of such entity’s operations once it commences scaled up operations. No interest
accrues on the loans, and no specific maturity date had been agreed upon. On March 10, 2021, the Company entered into a master revolving
note with Triple T Trading Company LLC to set forth the relationship of the parties to retain the previous terms of the note payable to
Triple T Trading Company LLC, to include a note maturity of March 10, 2023, and maximum lending amount of 1,481,482 QAR or approximately
$400,000, valued at an exchange rate of approximately $0.27 per QAR on March 10, 2021. |
(d) |
In May 2019, the Company purchased a vehicle for $36,432 and financed $34,932 over six years with an interest rate of 6.24% per annum.
Monthly payments of $485 are required and commenced in July 2019. |
(e) |
In 2020 the Company entered into various convertible promissory notes as follows: |
Throughout 2021 and 2020 the Company entered
into convertible promissory notes with an aggregate principal of $415,000.
The notes accrue interest at 10%
per annum and have a maturity of the earlier of 12 months or the consummation of the Company listing its Common Stock on a senior
stock exchange. The notes are convertible at the Company’s option into shares of the Company’s common stock at a price
equal to 80% of the opening price of the Company’s common stock on the national exchange or the offering price paid by the
investors in the financing in connection with the uplist, whichever is lower, or (ii) repaid in cash in an amount equal to the
indebtedness being repaid plus a premium payment equal to 15% of the amount being repaid. If an event of default has occurred and
the Company does not convert the amounts due under the Note into the Company’s common stock, then the Company will have the
option to convert the outstanding indebtedness into shares of the Company’s common stock at a price equal to 80% of the
weighted average trading price of the Company’s common stock on the OTC Markets, or be repaid in cash in an amount equal to
all principal and interest due under the Note. All of these notes were converted to common stock as of April 5, 2022.
On
October 13, 2020, the Company entered into a convertible promissory note in an amount of $280,500 having an interest rate of 12% per
annum. The note bears a 10% Original Issue Discount. The loan shall mature in 1 year and may be convertible at the lower of $12.00
or 80% of the lowest median daily traded price over ten trading days prior to conversion, but in the event of a Qualified Uplist the
note may be converted at a 30% discount to market. The Company also issued 3,333 restricted shares with no registration rights in
conjunction with this note, which was recorded as a debt discount in the amount of $44,000, which is amortized to interest
expense over the term of the agreements using the effective interest method. On March 28, 2021 the parties amended this agreement to
state that in no event shall the conversion price be lower than $3.00 per share. In October 2021 the parties agreed to extend the
maturity of this loan to April 13, 2022 in exchange for an increase in principal owed of $30,000. This note has been converted to
common stock as of March 21, 2022.
On
February 4, 2021, the Company entered into a convertible promissory note in an amount of $277,778 having an interest rate of 12% per
annum. The note bears a 10% Original Issue Discount. The loan shall mature in 1 year and may be convertible at the lower of $12.00
or 80% of the lowest median daily traded price over ten trading days prior to conversion, but in the event of a Qualified Uplist the
note may be converted at a 30% discount to market. The Company also issued 3,333 restricted shares with no registration rights in
conjunction with this note, which was recorded as a debt discount in the amount of $36,000, which is amortized to interest
expense over the term of the agreements using the effective interest method. On March 28, 2021 the parties amended this agreement to
state that in no event shall the conversion price be lower than $3.00 per share. In February 2022 the parties agreed to extend the
maturity of this loan to August 8, 2022 in exchange for an increase in principal owed of $25,000. This note has been converted to
common stock as of April 5, 2022.
(f) |
In May 2020, the Company entered into a Paycheck Protection Program (“PPP”) loan agreement
for $205,100 with Blue Ridge Bank, subject to the Small Business Administration’s (“SBA”) Paycheck Protection Program.
The loan carries an annual interest rate of one (1) percent per annum with payment beginning in the seventh month with monthly payments
required until maturity in the 18th month. The loan may be fully forgivable according to the CARES Act if the Company can
provide proper documentation for the use of the proceeds of the loan. The Company has achieved the milestones for loan forgiveness and
anticipates that this debt will be forgiven in full in 2021. On January 6, 2021 the Company was granted an extension of the PPP and granted
an additional $205,100 from Blue Ridge Bank, subject to the Small Business Administration’s (“SBA”) Paycheck Protection
Program. The loan carries an annual interest rate of one (1) percent per annum with payment beginning in the tenth month with monthly
payments required until maturity in five years. The loan may be fully forgivable according to the CARES Act if the Company can provide
proper documentation for the use of the proceeds of the loan. The Company has achieved the milestones for loan forgiveness, has applied
for loan forgiveness, and anticipates that this debt will be forgiven in full in 2022. |
(g) |
From May through August 2020, the Company entered into two loan agreements with the Small Business
Administration for an aggregate loan amount of $299,900. The loans carry an interest rate of 3.75% per annum. The loans shall mature
in 30 years. |
(h) |
In April 2021, the Company entered into a Paycheck Protection Program loan agreement with JP Morgan
Chase Bank, subject to the Small Business Administration’s (“SBA”) Paycheck Protection Program. The loan may be fully
forgivable according to the CARES Act if the Company can provide proper documentation for the use of the proceeds of the loan. The Company
has achieved the milestones for loan forgiveness and anticipates that this debt will be forgiven in full in 2022. |
(i) |
Viva Wealth Fund I, LLC is offering up to $25,000,000 in convertible notes in a private
offering. As of December 31, 2021, VWFI has raised $8,825,000 and converted $5,560,000 of this
debt to VWFI LLC units. A convertible note will automatically convert into the LLC units
at the earlier of (i) the date that the Equipment is placed into quality control and testing or (ii) six months from the date of investment.
The convertible notes will accrue interest at 12% per annum and are paid quarterly. At the maturity date, remaining interest will
be paid, at which time no further interest payments will accrue. Upon the offering termination date, all units accepted for any series
of equipment will automatically convert to Vivakor common stock if the Company has not accepted subscriptions for at least $6,250,000
for a series of equipment. The conversion price of the automatic stock conversion will be the the greater of $13.50 or a 10% discount to
market per share or in the event of a public offering, 200% of the per share price of the Company common stock sold in an underwritten
offering, which was closed on February 14, 2022 at $5.00 per share. The termination date
of the offering has been extended until November 13, 2022 in the sole discretion of the Company. As of March 21, 2021 VWFI has reached
$6,250,000 in funding and has released the funding for construction of RPC Series A. VWFI has commenced fundraising for RPC Series B and
has raised approximately $2,740,000 to manufacture RPC Series B. Subsequent to December 31, 2021 an additional $975,000 of this debt has
been converted into units of the LLC. |
Note 15. Commitments and Contingencies
Leases
In June 2019, the Company entered into a Sublease
agreement with US Closer, LLC, whereby we agreed to lease approximately 12,061 square feet of office and manufacturing space located in
South Salt Lake City, Utah. Pursuant to the Sublease, the sublease expired on December 31, 2020 and required a monthly lease payment of
$6,633 plus other pass-through expenses as required under the Primary Lease. The Company renegotiated with the landlord to renew this
lease as the primary tenant in January 2021 to lease this warehouse on a month-to-month basis. The lease may be terminated at any time
or for any reason with a 30-day written notice to terminate. The January 2021 lease requires a monthly lease payment of $6,833 plus other
pass-through expenses as required under the lease as long as the Company remains in the space. As a condition of the lease, we were required
to provide a $6,965 security deposit.
Commencing on September 15, 2019, the Company
entered into a five-year lease with Jamboree Center 1 & 2 LLC covering approximately 6,961 square feet of office space in Irvine,
CA. Under the terms of the lease agreement, we are required to make the following monthly lease payments: Year 1 $21,927, Year 2 $22,832,
Year 3 $23,737, Year 4 $24,712, Year 5 $25,686. As a condition of the lease, we were required to provide a $51,992 security deposit.
The right-of-use asset for operating leases as
of December 31, 2021 and 2020 was $663,291 and $881,804. Rent expense for the year ended December 31, 2021 and 2020 was $292,410 and $187,343.
The following table reconciles the undiscounted
cash flows for the leases as of December 31, 2021 to the operating lease liability recorded on the balance sheet:
Schedule of lessee operating lease liability | |
| | |
2022 | |
$ | 287,769 | |
2023 | |
| 299,466 | |
2024 | |
| 231,174 | |
2025 | |
| – | |
Total undiscounted lease payments | |
| 818,409 | |
Less: Abatement of rents | |
| – | |
Less: Imputed interest | |
| 96,531 | |
Present value of lease payments | |
$ | 721,878 | |
| |
| | |
Operating lease liabilities, current | |
$ | 287,769 | |
Operating lease liabilities, long-term | |
$ | 434,109 | |
| |
| | |
Weighted-average remaining lease term | |
| 3 | |
Weighted-average discount rate | |
| 7.0% | |
The discount rate is the Company’s incremental
borrowing rate, or the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term an
amount equal to the lease payments in a similar economic environment. Based on an assessment of the Company’s borrowings the incremental
borrowing rate was determined to be 7%.
Employment Agreements
In September 2020, the Company entered into an
employment agreement with the Chief Executive Officer and Chief Financial Officer, which provides for an annual base salary of $50,000
that provides for incremental increases upon the Company’s achievement of specific performance metrics up to $350,000. The employment
agreement provides for a grant of a stock option to the Chief Executive Officer to purchase up to 166,667 shares of the Company’s
common stock at an exercise price equal to 110% of the fair market value of the Company’s common stock on the date of grant. The
stock option will vest after five years of continuous employment, subject to acceleration if terminated without cause or resigns for good
reason. The agreement also provides for an annual bonus of up to 100% of the base salary based upon the achievement of certain performance
goals established and approved by the Board of Directors.
Note 16. Long-term Debt
To assist in funding the manufacture of the Company’s
Remediation Processing Centers, between 2015 and 2017, the Company entered into two agreements which include terms for the purchase of
participation rights for the sale of future revenue of the funded RPCs, and which also require working interest budget payments by the
Company.
The Company accounts for the terms under these
contracts for the sale of future revenue under Accounting Standards Codification 470 (“ASC 470”). Accordingly, these contracts
include the receipt of cash from an investor where the Company agrees to pay the investor for a defined period a specified percentage
or amount of the revenue or a measure of income (for example, gross revenue) according to their contractual right, in which the Company
will record the cash as debt and apply the effective interest method to calculate and accrue interest on the contracts. The terms of these
agreements grant the holder a prorated 25% participation in the gross revenue of the assets as defined in the agreements for 20 years
after operations commence for a purchase price of approximately $2,200,000. In the event that the contract is not fully subscribed, it will receive only a prorated participation of the available 25% participation. The Company made its first payment of $7,735
in the second quarter of 2021 and continues its quality control processes. The RPC is estimated to enter scaled up operations early 2022
and make estimated annual payments of $1,957,323. The Company estimates future payments based on revenue projections for the RPCs.
In accordance
with ASC 470, the Company records the proceeds from these contracts as debt because the Company has significant continuing involvement
in the generation of the cash flows due to the investor (for example, active involvement in the generation of the operating revenues of
the business segment), which constitutes the presence of a factor that independently creates a rebuttable presumption that debt classification
is appropriate. The Company has determined its effective interest rates to be between 32.6% and 33.76% based on each contract’s
future revenue streams expected to be paid to the investor. These rates represent the discount rate that equates estimated cash flows
with the initial proceeds received from the investor and is used to compute the amount of interest expense to be recognized each period.
During the development and manufacturing of the assets the effective interest has been capitalized to the assets. As the assets enter
operations or service of their intended use, the effective interest on these contracts will be recognized as interest expense (See Note
9).
In 2016 and 2017, additional consideration to
investors to enter into these agreements was granted, and the Company issued to these investors 113,000 shares of Series B-1 Preferred
Stock with a relative fair value of $7.50 per share or based on conversion terms and price of the Company’s Common Stock at the
time of issuance. The Company also issued 106,167 common stock warrants to investors. The relative fair value of the warrants and Series
B-1 preferred stock in aggregate was $1,488,550, and was recorded as a debt discount, which is amortized to interest expense over the
term of the agreements using the effective interest method. During the manufacturing phase of the asset, the interest expense is capitalized
to the asset.
Some holders of these participation rights also
have the option to relinquish ownership and all remaining benefits of their LLC units in exchange for Common Stock in the Company. Depending
on the contract, these options to convert to common stock range from between 1 and 5.5 years. The exercise period ranges from between
1 year to 5.5 years with a step-up discount to market for each year the option is not exercised with a range of between a 5% to a 25%
discount to market. Accordingly, under Accounting Standards Codification 815 (“ASC 815”) the Company valued these options
at fair value using a Monte Carlo Simulation by a third-party valuation expert, which found the fair value of the options to be nominal.
Long-term debt related to these participation rights is recorded in “Long-term debt” on the consolidated balance sheet.
The accounting for the terms under these contracts
that call for working interest budget payments by the Company are recorded in current liabilities on the consolidated balance sheet and
paid down through pass-through expenses or cash according to the contract. Accordingly, the Company records any unpaid balance of budget
payments received in “Long-term debt, current” as these liabilities are generally paid within 12 months after proceeds are
received.
Long-term debt consists of the following:
Schedule Of Long-Term Debt | |
| | | |
| | |
| |
December 31, | |
| |
2021 | | |
2020 | |
Principal | |
$ | 2,196,233 | | |
$ | 2,196,233 | |
Accrued interest | |
| 4,205,144 | | |
| 2,997,136 | |
Debt discount | |
| (226,823 | ) | |
| (241,709 | ) |
Total long term debt | |
$ | 6,174,554 | | |
$ | 4,951,660 | |
| |
| | | |
| | |
Long term debt, current | |
$ | 3,256 | | |
$ | 1,020 | |
Long term debt | |
$ | 6,171,298 | | |
$ | 4,950,640 | |
The following table sets forth the estimated
payment schedule of long-term debt as of December 31, 2021:
Schedule of long-term debt maturities | |
| | |
2022 | |
$ | 3,256 | |
2023 | |
| 8,685 | |
2024 | |
| 11,572 | |
2025 | |
| 15,420 | |
2026 | |
| 20,548 | |
Thereafter | |
| 2,136,752 | |
Total | |
$ | 2,196,233 | |
Note 17. Stockholders' Equity
Series A, Series B, Series B-1, Series C
and Series C-1 Preferred Stock
The Preferred Stock authorized by the Company
may be issued from time to time in one or more series. The Company is authorized to issue 15,000,000 shares of preferred stock. The Company
is authorized to issue 66,667 shares of Series A Preferred Stock, 3,266,667 shares of Series B Preferred Stock, 1,666,667 shares of Series
B-1 Preferred Stock, 3,333,333 shares of Series C Preferred Stock, and 3,333,333 shares of Series C-1 Preferred Stock. The Board of Directors
is authorized to fix or alter the number of shares constituting any series of Preferred Stock and the designation thereof. In 2021, the
Board of Directors authorized, and a majority vote acceptance was received of each voting class of preferred stock, including Series B
Preferred Stock, Series B-1 Preferred Stock, and Series C-1 Preferred Stock, that each class’s designations be amended that upon
the Company’s public offering in conjunction with an uplist to a senior stock exchange that these classes of preferred stock will
convert their preferred shares to common shares on a one for one basis.
The Company has issued 66,667
shares of Series A Preferred Stock, convertible at a current ratio of 10 shares of Common Stock for each outstanding share of
Series A Preferred Stock. The conversion price is subject to adjustment under certain customary circumstances, including as a result
of stock splits and combinations, dividends and distributions, and certain issuances of common stock. Holders of shares of Series A Preferred
Stock will have the right to 25 votes for each share of Common Stock into which such shares of Series A Preferred Stock can then be converted
(with a current conversion ratio of 10 shares of Common Stock for each outstanding share of Series A Preferred Stock) and the right to
a liquidation preference in any distribution of net assets made to the shareowners prior to and in preference to the holders of Common
Stock and any other Preferred Stock holder in the liquidation, dissolution or winding up of our Company. As of December 31, 2021 and
2020 the liquidation preference is $400,000.
Holders of shares of Series A Preferred Stock are not currently entitled to dividends. The Company has the right, but not the obligation,
to redeem shares of Series A Preferred Stock. All of the shares of Series A Preferred Stock were converted to common stock upon the close
of the Company’s public offering of the Company’s common stock on February 14, 2022.
The Company has issued none and 216,916 of Series
B Preferred Stock as of December 31, 2021 and 2020, respectively. Shares of Series B Preferred Stock are convertible one year after issuance,
at any time at the option of the holder, into shares of Common Stock (with a conversion price at the lesser of the issuance price ($6.00)
or a 10% discount to market on the conversion date). Automatic 1-for-1 conversion of all outstanding shares of Series B Preferred Stock
into shares of Common Stock occurred on May 1, 2021. No other shares have been issued since the conversion of all of the outstanding shares
of this class of stock. The conversion price is subject to adjustment under certain customary circumstances, including as a result of
stock splits and combinations, dividends and distributions, and certain issuances of common stock. The Company has the right, but not
the obligation, to redeem shares of Series B Preferred Stock one year after issuance. Holders of Series B Preferred Stock will have the
right to one vote for each share of Common Stock into which such Series B Preferred Stock is then convertible, and a right to a liquidation
preference in any distribution of net assets made to the shareowners prior to and in preference to the holders of Common Stock and any
Preferred Stockholder, except holders of Series A Preferred Stock, in the liquidation, dissolution or winding up of our Company. As of
December 31, 2021 and 2020 the liquidation preference was none and $1,341,233. Dividends are 12.5% and cumulative and are payable only
when, as, and if declared by the Board of Directors.
The Company has issued none and 467,728 of Series
B-1 Preferred Stock as of December 31, 2021 and 2020, respectively. Shares of Series B-1 Preferred Stock are convertible one year after
issuance, at any time at the option of the holder, into shares of Common Stock (with a conversion price at the lesser of the issuance
price ($7.50) or a 10% discount to market on the conversion date). Automatic 1-for-1 conversion of all outstanding shares of Series B-1
Preferred Stock into shares of Common Stock occurred on May 1, 2021. No other shares have been issued since the conversion of all of the
outstanding shares of this class of stock. The conversion price is subject to adjustment under certain customary circumstances, including
as a result of stock splits and combinations, dividends and distributions, and certain issuances of common stock. The Company has the
right, but not the obligation, to redeem shares of Series B-1 Preferred Stock one year after issuance. Holders of Series B-1 Preferred
Stock have no voting or dividend rights, and a right to a liquidation preference in any distribution of net assets made to the shareowners
prior to and in preference to the holders of Common Stock and any Preferred Stockholder, except holders of Series A and Series B Preferred
Stock, in the liquidation, dissolution or winding up of our Company. As of December 31, 2021 and 2020 the liquidation preference was none
and $3,507,981.
The Company has not issued any Series C Preferred
Stock as of December 31, 2021 and 2020, respectively. Shares of Series C Preferred Stock are convertible one year after issuance, at any
time at the option of the holder, into shares of Common Stock (with a conversion price at the lesser of the issuance price ($10.50) or
a 10% discount to the market price on the conversion date). Automatic conversion of shares of Series C Preferred Stock into shares of
Common Stock may occur due to certain qualified public offerings entered into or by written consent of a majority of the holders of Series
C Preferred Stock or upon the four-year anniversary date of the issuance of such shares. The conversion price is subject to adjustment
under certain customary circumstances, including as a result of stock splits and combinations, dividends and distributions, and certain
issuances of common stock. The Company has the right, but not the obligation, to redeem shares of Series C Preferred Stock one year after
issuance. Holders of Series C Preferred Stock will have the right to one vote for each share of Common Stock into which such Series C
Preferred Stock is then convertible, and a right to a liquidation preference in any distribution of net assets made to the shareowners
prior to and in preference to the holders of Common Stock and any Preferred Stockholder, except holders of Series B and B-1 Preferred
Stock, in the liquidation, dissolution or winding up of our Company. Dividends are 12.5% and cumulative and are payable only when, as,
and if declared by the Board of Directors.
The Company has issued none and 255,290 of Series
C-1 Preferred Stock as of December 31, 2021 and 2020, respectively. Shares of Series C-1 Preferred Stock are convertible one year after
issuance, at any time at the option of the holder, into shares of Common Stock (with a conversion price at the lesser of the issuance
price ($12.00) or a 10% discount to the market price on the conversion date). Automatic conversion of all outstanding shares of Series
C-1 Preferred Stock into shares of Common Stock occurred on May 4, 2021 by written consent of a majority of the holders of Series C-1
Preferred Stock. No other shares have been issued since the conversion of all of the outstanding shares of this class of stock. The conversion
price is subject to adjustment under certain customary circumstances, including as a result of stock splits and combinations, dividends
and distributions, and certain issuances of common stock. The Company has the right, but not the obligation, to redeem shares of Series
C-1 Preferred Stock one year after issuance. Holders of Series C-1 Preferred Stock have no voting or dividend rights, and a right to a
liquidation preference in any distribution of net assets made to the shareowners prior to and in preference to the holders of Common Stock
and any Preferred Stockholder, except holders of Series A, Series B, Series B-1, and Series C Preferred Stock, in the liquidation, dissolution
or winding up of our Company. As of December 31, 2021 and 2020 the liquidation preference was none and $3,063,472.
For the years ended December 31, 2021 and 2020,
$9,467,604 and $7,593,816 or 950,973 and 996,283 shares of Series B, Series B-1, and Series C-1 Preferred Stock were converted into 955,947
and 1,037,738 shares of Common Stock.
For the year ended December 31, 2021, the Company
issued 5,413 Series C-1 Preferred Stock or $64,950 for a reduction in stock payables.
For the years ended December 31, 2021 and 2020,
the Company issued 5,626 and 23,039 shares of Series B-1 Preferred Stock as a $42,196 and $172,795 stock dividend paid to Series B Preferred
Shareholders.
Common Stock
The Company is authorized to issue 41,666,667
shares of common stock. As of December 31, 2021 and 2020, there were 12,330,859 and 11,255,967 shares of our common stock issued and outstanding,
respectively. Treasury stock is carried at cost.
For the years ended December 31, 2021 and
2020, $9,467,604 and $7,593,816 or 950,973 and 996,283 shares of Series B, Series B-1, and Series C-1 Preferred Stock were converted
into 955,947 and 1,037,738 shares of Common Stock.
For the year ended December 31, 2020 the Company
issued 666,667 shares of Common Stock for a $11,800,000 reduction in stock payables.
As of December 31, 2021 and 2020, the
Company granted stock-based compensation to employees, including a 16,667 share
stock award, which vests at the end of four years, and a 166,667 stock
options that cliff vests at the end of five
years. For the years ended December 31, 2021 and 2020, stock-based compensation was $446,112 and
$146,114. As of December 31, 2021 and
2020, the Company also granted non-statutory stock options, including 133,333 stock
options to the Board of Directors, which vests over 1 year,
and a 333,334 stock
option to a consultant, which vests over 4 years.
Non-statutory stock-based compensation was $1,585,000 and
$555,000 for the years ended
December 31, 2021 and 2020.
For the years ended December 31, 2021 and 2020,
the Company issued 68,611 and 9,164 shares for a $495,799 and $135,993 reduction of liabilities.
For the years ended December 31, 2021 and 2020,
the Company issued 33,667 and 23,333 shares of Common Stock for $438,004 and $281,231 in services to the Company.
For the year ended December 31, 2021, the Company
issued 16,667 shares for a $225,000 payment for a technology license (see Note 10).
For the year ended December 31, 2020 the Company
issued 7,600 shares of Common Stock in the amount of $41,028 for cash.
Noncontrolling Interest
For the years ended December 31, 2021 and 2020,
the Company converted $5,560,000 and $2,720,000 in Viva Wealth Fund I, LLC convertible promissory notes into 1,112 and 544 units of noncontrolling
interest in Viva Wealth Fund I, LLC, and paid distributions to unit holders of $55,050 and none.
For the year ended December 31, 2020, the Company
issued 124,981 units of noncontrolling interest in RPC Design and Manufacturing LLC for cash of $624,907.
Note 18. Temporary Equity
Shares of Series B, B-1,
C and C-1 convertible preferred stock hold conversion features providing that, at the holder’s election, the holder may convert
the preferred stock into common stock. Upon conversion, the Company may be required to deliver a variable number of equity shares that
is determined by using a formula based on the market price of the Company’s Common Stock. After four years from the date of issuance,
Series C preferred shareholders are forced to automatically convert to Common Stock. On May 1, 2021, all outstanding shares of Series
B and B-1 converted at 1-for-1 to Common Stock. On May 4, 2021, all outstanding shares of Series C-1 converted at 1-for-1 to Common Stock.
For each respective series, the holder may convert their preferred shares to common shares at the original issue price as defined, which
ranges from between $6.00 per share to $12.00 per share, at the lesser of the original issue price or 90% of the market price on the conversion
date. As of December 31, 2020, the market price of the Company’s Common Stock was $15.00 per share. There is no contractual cap
on the number of common shares that the Company could be required to deliver on preferred shareholders’ conversions to Common Stock.
Accordingly, under ASC
815-40-25-10 the Company may be forced to settle these conversion features in cash, specifically since it is unknown as to what date the
shareholders’ may convert their preferred stock to common stock and if there will be sufficient authorized and unissued common shares
on that date. As of December 31, 2020 the Company did have sufficient authorized and unissued common shares to satisfy all preferred shareholders
interest if it were converted to Common Stock, although if the stock price were to drop below $0.60 per share and the Company may be forced
to settle such conversions in cash, which may consider them redeemable. Accordingly, Series B, B-1, C and C-1 preferred stock has been
classified in temporary equity.
The following table shows all changes to temporary equity
during for the years ended December 31, 2021 and 2020.
Schedule Of Temporary Equity | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
| |
Convertible Preferred Stock | |
| |
Series B | | |
Series B-1 | | |
Series C-1 | |
| |
Shares | | |
Amount | | |
Shares | | |
Amount | | |
Shares | | |
Amount | |
December 31, 2019 | |
| 708,396 | | |
$ | 4,250,380 | | |
| 758,623 | | |
$ | 5,689,690 | | |
| 446,159 | | |
$ | 6,841,409 | |
Dividend paid in Series B-1 Preferred Stock | |
| – | | |
| – | | |
| 23,039 | | |
| 172,795 | | |
| – | | |
| – | |
Conversion of Series B, B-1, and C-1 Preferred Stock to Common Stock | |
| (491,480 | ) | |
| (2,948,880 | ) | |
| (313,934 | ) | |
| (2,354,504 | ) | |
| (190,869 | ) | |
| (2,290,432 | ) |
December 31, 2020 | |
| 216,916 | | |
$ | 1,301,500 | | |
| 467,728 | | |
$ | 3,507,981 | | |
| 255,290 | | |
$ | 4,550,977 | |
Sercies C-1 Issue for a reduction in stock payables | |
| – | | |
| – | | |
| – | | |
| – | | |
| 5,413 | | |
| 64,950 | |
Dividend paid in Series B-1 Preferred Stock | |
| – | | |
| – | | |
| 5,626 | | |
| 42,196 | | |
| – | | |
| – | |
Conversion of Series B and B-1 Preferred Stock to Common Stock | |
| (216,916 | ) | |
| (1,301,500 | ) | |
| (473,354 | ) | |
| (3,550,177 | ) | |
| (260,703 | ) | |
| (4,615,927 | ) |
December 31, 2021 | |
| – | | |
$ | – | | |
| – | | |
$ | – | | |
| – | | |
$ | – | |
Note 19. Share-Based Compensation & Warrants
Options
Generally accepted accounting principles require
share-based payments to employees, including grants of employee stock options, warrants, and common stock to be recognized in the income
statement based on their fair values at the date of grant, net of estimated forfeitures.
As of December 31, 2021 and 2020, the Company
has granted stock-based compensation to employees, including a 16,667
share stock award, which was issued in 2018 and vests at the end of four years, and a 166,667
stock options that was issued in 2020 and cliff vests at the end of five years. For the years ended December 31, 2021 and 2020,
stock-based compensation was $446,112
and $146,114.
In 2020, the Company also granted non-statutory stock options, including 133,333
stock options to the Board of Directors, which vests over 1 year, and a 333,334
stock option to a consultant, which vests over 4 years. Non-statutory stock-based compensation was $1,585,000
and $555,000
for the years ended December 31, 2021 and 2020.
There were no other options granted during the
years ended December 31, 2021 and 2020, respectively.
The assumptions used in the Black-Scholes option
pricing model to determine the fair value of the options on the date of issuance are as follows:
|
|
Year Ended
December 31, 2020 |
Risk-free interest rate |
|
0.27 - 0.38% |
Expected dividend yield |
|
None |
Expected life of warrants |
|
5-10 years |
Expected volatility rate |
|
187 - 273% |
The following table summarizes all stock option
activity of the Company for the years ended December 31, 2021 and 2020:
Schedule of option activity | |
| | | |
| | | |
| | |
| |
| | |
| | |
Weighted | |
| |
| | |
Weighted | | |
Average | |
| |
| | |
Average | | |
Remaining | |
| |
Number | | |
Exercise | | |
Contractual | |
| |
of Shares | | |
Price | | |
Life (Years) | |
| |
| | |
| | |
| |
Outstanding, December 31, 2019 | |
| 16,667 | | |
$ | 11.10 | | |
| 1.42 | |
| |
| | | |
| | | |
| | |
Granted | |
| 633,333 | | |
| 12.32 | | |
| 8.71 | |
Exercised | |
| – | | |
| – | | |
| – | |
Forfeited | |
| – | | |
| – | | |
| – | |
Outstanding, December 31, 2020 | |
| 650,000 | | |
$ | 12.00 | | |
| 8.53 | |
| |
| | | |
| | | |
| | |
Outstanding, December 31, 2021 | |
| 650,000 | | |
$ | 12.00 | | |
| 7.53 | |
| |
| | | |
| | | |
| | |
Exercisable, December 31, 2020 | |
| 47,083 | | |
$ | 12.00 | | |
$ | 6.93 | |
Exercisable, December 31, 2021 | |
| 180,000 | | |
$ | 12.00 | | |
$ | 7.01 | |
As of December 31, 2021 and 2020, the aggregate
intrinsic value of the Company’s outstanding options was approximately none. The aggregate intrinsic value will change based on
the fair market value of the Company’s common stock.
Warrants
As of December 31, 2021 and 2020, the Company
had no warrants outstanding. These expired or exercised warrants during the year ended December 31, 2020 relate to the warrants issued
as an incentive to investors with an investment into the Company. The warrants were issued at $12.00 per share of Common Stock. The warrants
were granted for a one-year period.
Management uses the Black-Scholes option pricing
model to determine the fair value of warrants on the date of issuance. The fair value of warrants issued pursuant to the issuance of notes
payable was recorded as deferred debt issuance cost and amortized over the remaining term of the associated debt.
The assumptions used in the Black-Scholes option pricing model to
determine the fair value of the warrants on the date of issuance are as follows:
Schedule of warrant assumptions | |
|
Risk-free interest rate | |
1.2% |
Expected dividend yield | |
None |
Expected life of warrants | |
1 years |
Expected volatility rate | |
119% |
The following table summarizes the activity of
the Company’s share purchase warrants:
Schedule of warrant activity | |
| | | |
| | | |
| | |
| |
| | |
Weighted | | |
| |
| |
| | |
average | | |
Aggregate | |
| |
Number of | | |
exercise | | |
Intrinsic | |
| |
warrants | | |
price | | |
Value | |
Balance, December 31, 2019 | |
| 36,000 | | |
$ | 12.00 | | |
$ | – | |
Expired | |
| (35,333 | ) | |
| 12.00 | | |
| | |
Exercised | |
| (667 | ) | |
| 12.00 | | |
| | |
Balance, December 31, 2020 | |
| – | | |
$ | – | | |
$ | – | |
There were no share purchase warrants outstanding
as of December 31, 2021 and 2020.
Note 20. Income Tax
Provision (benefit) for income taxes is as follows:
Schedule of components of income tax | |
| | | |
| | |
| |
December 31, | |
| |
2021 | | |
2020 | |
Current: | |
| | |
| |
State | |
$ | 800 | | |
$ | 800 | |
Total current | |
| 800 | | |
| 800 | |
Deferred: | |
| | | |
| | |
Federal | |
| (718,868 | ) | |
| 336,124 | |
State | |
| (332,139 | ) | |
| 130,040 | |
Total Deferred | |
| (1,051,007 | ) | |
| 466,164 | |
| |
| | | |
| | |
Net provision (benefit) | |
$ | (1,050,207 | ) | |
$ | 466,964 | |
The differences between the expected income tax benefit based on the
statutory Federal United States income tax rates and the Company's effective tax rates are summarized below:
Schedule reconciliation of income tax | |
| | | |
| | |
| |
December 31, 2021 | |
Tax Computed At The Federal Statutory Rate | |
$ | (1,338,184 | ) | |
| 21.00% | |
State Tax, Net Of Federal Tax Benefit | |
| (263,892 | ) | |
| 4.14% | |
Nondeductible Expenses | |
| 85,025 | | |
| -1.33% | |
Flowthrough Entity not Subject to Tax | |
| 454,587 | | |
| -7.13% | |
Foreign Corporation - Minority Interest | |
| 3,140 | | |
| -0.05% | |
Valuation Allowance | |
| 9,117 | | |
| -0.14% | |
Benefit for income taxes | |
$ | (1,050,207 | ) | |
| 16.48% | |
| |
December 31, 2020 | |
Tax Computed At The Federal Statutory Rate | |
$ | (447,850 | ) | |
| 21.00% | |
State Tax, Net Of Federal Tax Benefit | |
| (77,025 | ) | |
| 3.54% | |
Nondeductible Expenses | |
| 22,040 | | |
| -1.03% | |
Flowthrough Entity not Subject to Tax | |
| 187,948 | | |
| -8.81% | |
Foreign Corporation - Minority Interest | |
| 8,996 | | |
| -0.42% | |
Valuation Allowance | |
| 772,855 | | |
| -36.24% | |
Provision for income taxes | |
$ | 466,964 | | |
| -21.96% | |
Significant components of the Company's deferred tax assets and liabilities
are as follows:
Schedule of deferred tax assets and liabilities | |
| | |
| |
December 31, 2021 | |
Reserves | |
$ | 336,875 | |
Fixed Assets | |
| (1,915,092 | ) |
Leases | |
| 16,395 | |
Intangibles | |
| (3,622,638 | ) |
Net Operating Losses | |
| 3,553,164 | |
Impairment Losses | |
| – | |
Stock Options | |
| 598,849 | |
Accruals | |
| (32,905 | ) |
Other | |
| (393,154 | ) |
Net Deferred Liability | |
| (1,458,506 | ) |
Less: Valuation Allowance | |
| (3,698,393 | ) |
Total deferred tax liability: | |
$ | (5,156,899 | ) |
| |
| | |
| |
December 31, 2020 | |
Reserves | |
$ | 336,875 | |
Fixed Assets | |
| (1,915,021 | ) |
Leases | |
| 3,803 | |
Intangibles | |
| (3,964,173 | ) |
Net Operating Losses | |
| 3,544,614 | |
Impairment Losses | |
| – | |
Stock Options | |
| 155,309 | |
Accruals | |
| 19,440 | |
Other | |
| (699,478 | ) |
Net Deferred Liability | |
| (2,518,629 | ) |
Less: Valuation Allowance | |
| (3,689,275 | ) |
Total deferred tax liability: | |
$ | (6,207,905 | ) |
In determining the possible future realization
of deferred tax assets, the Company has considered future taxable income from the following sources: (a) reversal of taxable temporary
differences; and (b) tax planning strategies that, if necessary, would be implemented to accelerate taxable income into years in which
net operating losses might otherwise expire.
Deferred tax assets are recognized subject to
management’s judgment that realization is more likely than not. A valuation allowance is recognized for a deferred tax asset if,
based on the weight of the available evidence, it is more likely than not that some portion of the deferred tax asset will not be realized.
In making such judgments, significant weight is given to evidence that can be objectively verified. Based on our review of the deferred
tax assets the Company has concluded that a valuation allowance is necessary on the net operating loss balance, as realization of this
asset does not meet the more likely than not threshold.
As of December 31, 2021 and 2020, the
Company had estimated net operating losses for federal and state purposes of $14.3
and 11.7 million, respectively. Federal and state net operating losses will begin to expire in 2028.
We recognize a tax position as a benefit only
if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being
presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination.
For tax positions not meeting the “more
likely than not” test, no tax benefit is recorded. We recognize potential interest and penalties related to unrecognized tax benefits
in the general and administrative expense in the statement of operations of the Company.
The Company is in the process of filing back income
tax returns from 2010 through the current year and subject to IRS examination for these years. The Company has booked a reserve for potential
penalties associated with non-filing of certain foreign information reports related to its subsidiary in the Middle East. Penalties and
interest have been reported in the general and administrative section of the statement of operations. The reserve balance at December
31, 2021 and 2020 was $289,000 and $238,000, respectively. The Company does not expect this reserve to reverse within the next 12 months,
as they will apply for a penalty waiver when the tax returns are ultimately filed. Due to the non-filing of income tax returns, statutes
of limitations on the potential examination of those income tax periods will continue to run until the returns are filed, at which time
the statutes will begin. The Company expects to file all past due income tax returns within the next 12 months.
Note 21. Related Party Transactions
The Company provided secured loan financing and
assistance to the development and commercialization of two bioactive beverages and one weight loss beverage for Vivaceuticals, Inc., which
shared a common officer and board of director member with the Company. Vivaceuticals sold its assets to Scepter Holdings, Inc. in 2018.
In 2019, the Company received 800,000 shares of preferred stock in Scepter Holdings, Inc. to extinguish the loan encumbering the assets.
The Company has converted these preferred shares into 800,000,000 shares of Common Stock of Scepter Holdings, Inc., which is traded on
the OTC Markets (ticker: BRZL) (see Note 3). In 2019 we entered into a Convertible Master Revolving Note with Scepter and over the course
of approximately two years lent them $71,000, which accrued 7% interest per annum (see Note 8). As of December 31, 2021 the principal
balance with all accrued interest was $81,768 and converted into 26,376,882 shares of Scepter common stock pursuant to the terms of the
note at $0.0031 per share. On the date of the conversion, the Scepter price per share on OTC Markets was $0.0062 per share, which resulted
in a $87,044 gain on the disposition of the note receivable. As of December 31, 2021, the Company’s Chief Executive Officer has
an immediate family member who sits on the board of directors of Scepter Holdings, Inc.
The Company has a consulting contract with LBL
Professional Consulting, Inc. (“LBL”), which shares a common officer with the Company. For the years ended December 31, 2021
and 2020, LBL was paid $188,150 and $191,295 for services rendered. On December 17, 2020, the Company granted non-statutory stock options
to LBL for 333,334 shares of Common Stock. The stock options vest over four years. The stock options are exercisable for up to ten years
from the grant date. The common officer is not the beneficiary of the Company and is not permitted to participate in any discussion, including
the LBL’s board meetings, regarding any Company stock that LBL may own at any time.
In July 2020, the Company entered into an
agreement with IME giving IME the option to purchase approximately 1,331 ounces of our precious metal concentrate for approximately
$2,800,000. VVMCI, a wholly owned subsidiary of Vivakor, Inc. owns all of the Class A Units of IME, which have sole voting power for
all material matters except for removal of the manager, and VVMCI serves as a manager of IME. For the year ended December 31, 2021
and 2020, the Company sold none and $54,250, respectively,
of the precious metal concentrate through this option.
The Company has a note payable to Triple T, which
is owned by the 51% majority-owner of Vivakor Middle East LLC. As of December 31, 2021 and 2020 the balance owed was $353,330 and $376,972.
On January
20, 2021, the Company entered into a worldwide, exclusive license agreement with TBT Group, Inc. (of which an independent Vivakor Board
member is a 7% shareholder) to license piezo electric and energy harvesting technologies for creating self-powered sensors for making
smart roadways. The Company is required to pay $25,000 and 16,667 shares of restricted common stock upon signing. Upon
the earlier of (i) 120 days or (ii) the effectiveness of the Company's Registration Statement and receipt of public offering proceeds,
the Company will pay licensor $225,000. When the licensor delivers to the Company data showing
that the sensor performs based on mutually defined specifications and all designs for the sensor are completed, Company shall pay an
additional $250,000 and 16,667 shares of restricted common stock. Upon the delivery of a mutually agreed working prototype, Company will
pay licensor $250,000 and 16,667 shares of restricted common stock. Upon commercialization of the product, the Company will pay licensor
$250,000 and 33,333 shares of restricted common stock. TBT shall have the option, at its sole discretion, to convert the license to a
non-exclusive license if the Company fails to pay $500,000 to TBT for sensor inventory per year, which will commence after the second
anniversary of product commercialization. The Company shall share in the development costs of the sensor technology to the time of commercialization.
Total costs attributed to the Company are estimated to be $125,000. From May, 2021 through March 3, 2022, the parties amended the license
agreement to extend the terms of the first milestone to March 4, 2022, of which we paid $15,000 as consideration for the extensions and
$225,000 to be paid on March 4, 2022.
As of December 31, 2020, the Company had a common
board of directors member with CannaPharmaRx Inc. The Company has a $33,000 account receivable with CannaPharmaRx Inc. for leasing office
space to this entity. As of December 31, 2020, the Company recorded an allowance for doubtful accounts on these receivables in the amount
of $33,000. As of January 1, 2021 the Company no longer leases office space to this entity.
Note 22. Subsequent Events
The Company has evaluated subsequent events through the date the financial statements were available to issue.
On February 1, 2022, the Company entered into
a lease agreement for approximately 2,533 square feet of office and manufacturing space located in Las Vegas, Nevada. Commencing on March
1, 2022, the Company entered into a three-year lease with Speedway Commerce Center, LLC. Under the terms of the lease agreement, we are
required to make the following monthly lease payments: Year 1 $1,950, Year 2 $2,028, Year 3 $2,110. As a condition of the lease, we were
required to provide a $2,418 security deposit.
On February 14, 2022, the Company closed on its
underwritten public offering of 1,600,000 shares of common stock, at a public offering price of $5.00 per share, for aggregate
gross proceeds of $8.0 million, prior to deducting underwriting discounts, commissions, and other offering expenses. In addition,
the Company has granted the underwriter, EF Hutton, division of Benchmark Investments, LLC ("EF Hutton"), a 45-day option
to purchase up to an additional 240,000 shares of Common Stock at the public offering price per share, less the underwriting discounts
and commissions, to cover over-allotments, if any. The Company's Common Stock began trading on the Nasdaq Capital Market on February
14, 2022, under the symbol "VIVK". EF Hutton, acted as sole book-running manager for the offering. Simultaneous with the close
of the offering, the Company converted 66,667 shares of Series A Preferred Stock in to 833,333 shares of common stock. The Company effected
a 1-for-30 reverse split of our outstanding shares of common stock (the “Reverse Stock Split”) via the filing of a certificate
of change with the Nevada Secretary of State simultaneously with the close of the underwritten public offering, which was effective at
the commencement of trading of our Common Stock. No fractional shares of the Company’s common stock were issued as a result of the
Reverse Stock Split. Any fractional shares resulting from the Reverse Stock Split were rounded up to the nearest whole share, resulting
in a round up issuance of 2,271 shares of common stock. In conjunction with the offering, approximately $1,228,997 in convertible notes
payable were converted into 272,156 shares of common stock. All issued and outstanding common stock, preferred stock, and per share amounts
in the consolidated financial statements and footnotes included herein have been retroactively adjusted to reflect this reverse stock
split for all periods presented.
On March
3, 2022, the Company amended our TBT license agreement to extend the terms of the first milestone to March 4, 2022.
On March 9, 2022, entered into a land lease agreement
for located in Vernal, Utah, which allows the Company to operate on the land and receive ore supply of 2,000 tons per day of oil
sand material, which is guaranteed by the land owner to be at a minimum of 10% hydrocarbon by weight. Commencing in March 2022, the Company
entered into a five-year lease, with an optional additional five-year extension, with Tar Sands Holdings II, LLC. Under the terms of the
lease agreement, we are required to pay $3 per ton of oil sands processed. As a condition of the lease, we were required to provide a
$30,000 prepayment toward tons of oil sands processed.
On March 28, 2022, the Company entered into a
lease agreement for approximately 1,469 square feet of office space located in Lehi, Utah. Commencing on April 1, 2022, the Company entered
into a three-year lease with Victory Holdings, LLC. Under the terms of the lease agreement, we are required to make the following monthly
lease payments: Year 1 is comprised of April to May 2022 $867, June 2022 to March 2023 $3,550, Year 2 $3,657, Year 3 $3,766. As a condition
of the lease, we were required to provide a $3,766 security deposit.
On April 1, 2022, the Company entered into a lease
agreement for approximately 2,000 square feet of office and warehouse space located in Houston, Texas. Commencing on April 1, 2022, the
Company entered into a month-to-month lease with JVS Holdings, Inc. The lease may be terminated at any time or for any reason with a 30-day
written notice to terminate. The lease requires a monthly lease payment of $2,000 as long as the Company remains in the space.
On April 26, 2022, the Company entered into a 10-year contract with
Hot Oil Transport, LLC, a supplier of asphalt materials. The quantity of product purchased pursuant to the agreement shall be 1,000
tons of product per week, or the entirety of any lesser amount that may be produced by the Company during any given week. Buyer shall
also have the first right of refusal to purchase all or any portion of additional product that may be produced by the Company within the
state of Utah. Subject to the Company’s right to continue operating at the current plant site in Vernal, the agreement shall automatically
renew for two successive 10-year terms unless either party terminates the agreement by written notice to the other party not less than
three months prior to the expiration of the initial term or any renewal term.
Subsequent to December 31, 2021, VWFI has raised
$295,000 in conjunction with the $25,000,000 private placement offering to sell convertible promissory notes, which convert to VWFI LLC
units, to accredited investors to raise funds to manufacture equipment that manufacture RPC Series B. Subsequent to December 31, 2021,
VWFI has also converted $1,320,000 of convertible debt into VWFI LLC units.
Subsequent to December 31, 2021, VWFI has raised
$295,000 in conjunction with the $25,000,000 private placement offering to sell convertible promissory notes, which convert to VWFI LLC
units, to accredited investors to raise funds to manufacture equipment that manufacture RPC Series B. Subsequent to December 31, 2021,
VWFI has also converted $2,235,000 of convertible debt into VWFI LLC units.
Subsequent to December 31, 2021 the Company amended
a note payable with a principal balance of $334,775 to extend the note’s maturity date to April 1, 2023, with monthly payments of
approximately $29,432 until paid in full.
Note 23. Restatement of Previously Issued Financial Statements
Subsequent to the filing
of the December 31, 2021 Form 10-K, the Company became aware of scrivener’s errors in its filing, which led to incorrect financial
information being inadvertently filed in the Form 10-K, including the correction of interest expense to reflect a reduction in the amount
of $398,954 and certain other adjustments. Management determined it should restate its previously reported financial statements. The Company
noted that financial statements were appropriately prepared, but due to these scrivener’s errors an incorrect version was filed
on April 15, 2022.
The impact of the restatement on the Company’s
financial statements is reflected in the following table:
| |
As Reported | | |
Adjustment | | |
As Restated | |
Consolidated Balance Sheet as of December 31, 2021 | |
| | |
| | |
| |
Property and equipment, net | |
$ | 24,293,157 | | |
$ | 398,954 | | |
$ | 24,692,111 | |
Total assets | |
$ | 47,345,291 | | |
$ | 398,954 | | |
$ | 47,744,245 | |
Noncontrolling interest | |
$ | 4,613,550 | | |
$ | 398,954 | | |
$ | 5,012,504 | |
Total stockholders' equity | |
$ | 27,154,179 | | |
$ | 398,954 | | |
$ | 27,553,133 | |
Total liabilities and stockholders’ equity and temporary equity | |
$ | 47,345,291 | | |
$ | 398,954 | | |
$ | 47,744,245 | |
Consolidated Statement of Operations for the Year Ended December 31, 2021 | |
| | | |
| | | |
| | |
Interest expense | |
$ | 900,552 | | |
$ | (398,954 | ) | |
$ | 501,598 | |
Total other income (expense) | |
$ | (1,778,951 | ) | |
$ | 398,954 | | |
$ | (1,379,997 | ) |
Loss before provision for income taxes | |
$ | (8,704,867 | ) | |
$ | 398,954 | | |
$ | (8,305,913 | ) |
Consolidated net loss | |
$ | (7,654,660 | ) | |
$ | 398,954 | | |
$ | (7,255,706 | ) |
Less: Net loss attributable to noncontrolling interests | |
$ | (2,170,489 | ) | |
$ | 398,954 | | |
$ | (1,771,535 | ) |
Statement of Changes in Stockholders’ Equity (Deficit) December 31, 2021 | |
| | | |
| | | |
| | |
Net loss, Noncontrolling interest | |
$ | (2,170,489 | ) | |
$ | 398,954 | | |
$ | (1,771,535 | ) |
Net loss, Total Stockholders' Equity (Deficit) | |
$ | (7,654,660 | ) | |
$ | 398,954 | | |
$ | (7,255,706 | ) |
Noncontrolling interest as of December 31, 2021 | |
$ | 4,613,550 | | |
$ | 398,954 | | |
$ | 5,012,504 | |
Total Stockholders' Equity (Deficit) as of December 31, 2021 | |
$ | 27,154,179 | | |
$ | 398,954 | | |
$ | 27,553,133 | |
Consolidated Statement of Cash Flows for the Year Ended December 31, 2021 | |
| | | |
| | | |
| | |
Consolidated net loss | |
$ | (7,654,660 | ) | |
$ | 398,954 | | |
$ | (7,255,706 | ) |
Accrued interest on notes payable | |
$ | 900,552 | | |
$ | (398,954 | ) | |
$ | 501,598 | |
Capitalized interest on construction in process | |
$ | 1,215,743 | | |
$ | 398,954 | | |
$ | 1,614,697 | |
Note 9 Property and Equipment | |
| | | |
| | | |
| | |
Remediation Processing Unit System A, Gross Carrying Amount | |
$ | 2,253,967 | | |
$ | 307,500 | | |
$ | 2,561,467 | |
Remediation Processing Unit System B, Gross Carrying Amount | |
$ | 2,253,967 | | |
$ | 91,454 | | |
$ | 2,345,421 | |
Total Fixed Assets, Gross Carrying Amount | |
$ | 25,083,463 | | |
$ | 398,954 | | |
$ | 25,482,417 | |
Remediation Processing Unit System A, Net Book Value | |
$ | 2,253,967 | | |
$ | 307,500 | | |
$ | 2,561,467 | |
Remediation Processing Unit System B, Net Book Value | |
$ | 2,253,967 | | |
$ | 91,454 | | |
$ | 2,345,421 | |
Total Fixed Assets, Net Book Value | |
$ | 24,293,157 | | |
$ | 398,954 | | |
$ | 24,692,111 | |
3,009,552 Shares of Common Stock
Vivakor, Inc.
____________________________________
PROSPECTUS
____________________________________
, 2022